Covid-19 suspected case

U22_COVID19_SUSPECTED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — U072 Cause of death: ICD-10 — U072 2 out of 7 registries used, show all original rules.	12082
4. Check minimum number of events None	12082
5. Include endpoints None	12082
6. Filter based on genotype QC (FinnGen only)	10675

Control definitions (FinnGen only)

Control conditions: not U22_COVID19_CONFIRMED

Extra metadata

First used in FinnGen datafreeze: DF6

NAME	U22_COVID19_SUSPECTED
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!U22_COVID19_CONFIRMED
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	U072
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	U072
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Covid-19 suspected case based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	50989	30684	19963
Only index persons	42809	26970	15839
Unadjusted period prevalence (%)
Whole population	0.75	0.88	0.56
Only index persons	0.85	0.99	0.60
Median age at first event (years)
Whole population	33.88	35.56	31.28
Only index persons	38.32	38.63	37.78

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10675	7141	3534
Unadjusted period prevalence (%)	2.23	2.54	1.62
Median age at first event (years)	53.29	50.26	59.41

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
11190: Matched controls
111898

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

10.6

316.8

351

342

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.6

307.7

1445

4440

U07.2

ICD-10 Finland

COVID-19, virus not identified

14237.1

307.7

11186

18316

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

9.3

307.7

527

591

J12.8

ICD-10 Finland

Other viral pneumonia

50.1

282.7

163

A77

ICPC

Viral disease other/NOS

3.8

239.4

787

2208

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

235.1

2778

14988

R83

ICPC

Respiratory infection other

1.9

228.4

4073

25421

Z3231

NOMESCO Finland

Registered nurse

2.0

227.3

3245

18743

R4135

NOMESCO Finland

Rehabilitation for hearing problems

7.3

217.5

323

454

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.2

189.3

1864

9276

Z50.1

ICD-10 Finland

Other physical therapy

3.2

171.3

714

2323

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.3

160.9

1435

6825

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

153.5

4311

29951

SCB01

NOMESCO Finland

Instructions for self-performed oral hygiene, short

6.4

152.5

254

403

SPAT1312

SPAT

General health counselling

1.7

150.7

3895

26415

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

5.8

142.1

263

463

WVA20

NOMESCO Finland

Medicine administration

3.8

140.6

448

1224

Z36.8

ICD-10 Finland

Other antenatal screening

3.8

137.3

427

1147

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

5.6

134.5

259

473

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

132.4

2318

13949

XQ845

NOMESCO Finland

Dermatoscopy

4.7

129.0

302

654

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.4

128.0

984

4371

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

25.9

122.8

SPAT1059

SPAT

Spirometry at the office

2.9

122.0

616

2228

SPAT1257

SPAT

Teaching of medicine inhalation technique

3.4

117.5

436

1316

HANKE, ,

NOMESCO Finland

18.7

115.1

A23

ICPC

Risk factor NOS

2.0

109.0

1373

7379

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

107.5

885

4040

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.3

107.1

407

1247

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

107.0

3619

25759

SPAT1165

SPAT

Peritoneal dialysis

42.2

104.9

R4110

NOMESCO Finland

Physiotherapy

1.6

98.8

2763

18708

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.8

98.5

303

807

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

7.0

87.7

134

194

MAC99

NOMESCO Finland

Other augmentation of labor

23.5

87.6

K28

ICPC

Limited function/disability (K)

4.1

85.5

242

607

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

84.4

2232

14820

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

83.2

2105

13818

Z01.7

ICD-10 Finland

Laboratory examination

1.7

83.0

1912

12251

WYA00

NOMESCO Finland

Screening and health check-up

3.9

81.4

246

647

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

77.5

2024

13364

SPAT1127

SPAT

Enema

7.4

75.6

109

148

SPAT1057

SPAT

Peak expiratory flow measurement

3.2

75.1

300

947

L28

ICPC

Limited function/disability (L)

1.7

74.1

1582

9908

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

71.1

3306

24715

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

67.6

2592

18596

Z36.1

ICD-10 Finland

Antenatal screening for raised alphafetoprotein level

7.0

67.5

103

149

R06.0

ICD-10 Finland

Dyspnoea

1.5

67.2

2481

17658

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.1

66.5

283

928

CS2P4

NOMESCO Finland

Optic nerve head imaging

5.4

64.5

127

237

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

63.9

6398

54561

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

63.1

3295

25066

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

63.0

2107

14652

R50.9

ICD-10 Finland

Fever, unspecified

1.6

62.8

1565

10163

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

62.8

561

11075

SPAT1279

SPAT

Preparation of immediate hospitalisation

5.6

62.4

118

212

SPAT1062

SPAT

Lung clearance therapy

12.9

61.3

R02

ICPC

Shortness of breath/dyspnoea

1.7

61.0

1316

8233

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

61.0

1075

6363

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

60.8

939

5342

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.1

60.8

170

423

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

60.2

1801

12202

A98

ICPC

Health maint/preventive medicine

3.1

58.7

10996

106057

SPAT1324

SPAT

Screening procedure

1.5

58.6

2055

14412

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

58.5

879

4958

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.7

57.7

306

1133

R05

ICPC

Cough

1.5

57.3

2687

19963

XF602

NOMESCO Finland

Bloodpressure monitoring

4.2

56.8

152

366

SPAT1172

SPAT

Guidance concerning hydration

3.5

56.6

200

585

XCW10

NOMESCO Finland

Assessment of vision

3.7

56.5

184

510

A10BA02

ATC

metformin; oral

1.5

56.1

2242

16134

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

55.2

383

1616

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.9

54.6

160

412

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

53.6

2453

18104

WX402

NOMESCO Finland

General anaesthesia

1.5

53.4

2283

16626

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.0

53.0

605

3113

SPAT1138

SPAT

Guidance concerning bowel function

3.4

53.0

190

561

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

52.7

4014

32349

RTGKO, ,

NOMESCO Finland

10.4

52.5

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.8

51.3

799

4550

A02BC02

ATC

pantoprazole; systemic

1.4

51.3

6635

57936

A10AB05

ATC

insulin aspart; parenteral

1.9

50.4

715

3956

R03AC02

ATC

salbutamol; inhalant

1.3

50.4

5817

49861

Z46.7

ICD-10 Finland

Fitting and adjustment of orthopaedic device

9.7

50.0

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

49.8

1214

7810

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

49.7

582

3021

E66.00

ICD-10 Finland

Metabolic syndrome

2.0

49.1

556

2853

R4180

NOMESCO Finland

Podiatric therapy

3.8

49.0

151

403

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

4.5

49.0

120

270

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

48.0

1021

6345

WX722

NOMESCO Finland

PEEP

2.3

47.4

387

1751

J01CF05

ATC

flucloxacillin; systemic

1.8

47.3

764

4397

R01AD09

ATC

mometasone; nasal

1.3

47.0

4933

41515

SPAT1263

SPAT

Sampling

1.3

46.2

4243

34983

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

46.2

994

6192

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

46.2

1480

10131

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

5.7

45.6

151

D01

ICPC

Abdominal pain/cramps general

1.5

45.4

1455

9955

K01.17

ICD-10 Finland

Retained molar with obstruction in the lower jaw

2.1

45.3

446

2173

J01MA02

ATC

ciprofloxacin; systemic

1.4

44.5

3362

26874

ZB0.1

ICD-10 Finland

Right side

15.9

44.3

R42

ICD-10 Finland

Dizziness and giddiness

1.4

44.1

2026

14891

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

44.0

3816

31132

WX199

NOMESCO Finland

Other local analgesia

2.4

43.4

311

1331

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

43.3

444

2197

ZXA10

NOMESCO Finland

Bilateral

1.5

42.8

1532

10718

R53

ICD-10 Finland

Malaise and fatigue

1.4

42.6

2605

20104

Z71.8

ICD-10 Finland

Other specified counselling

1.3

42.6

3744

30569

SPAT1304

SPAT

Counselling and guidance related to ageing

2.1

42.5

438

2172

J45

ICD-10 Finland

Asthma

1.6

42.1

1089

7093

A10AE05

ATC

insulin detemir; parenteral

2.0

40.9

489

2556

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

40.8

1155

7677

A10AE06

ATC

insulin degludec; parenteral

2.1

40.7

376

1788

LCA96

NOMESCO Finland

Other intrauterine operation

4.5

40.7

100

226

A10AE04

ATC

insulin glargine; parenteral

1.7

39.8

793

4837

Z09.9

ICD-10 Finland

Follow-up examination after unspecified treatment for other conditions

3.4

39.2

140

413

SPAT1125

SPAT

Stoma care and guidance

3.5

38.5

130

370

T90

ICPC

Diabetes non-insulin dependent

1.4

38.4

1778

13048

XMA22

NOMESCO Finland

General examination of pregnant woman

1.7

38.3

670

3940

ZXA05

NOMESCO Finland

Left side

1.4

38.3

1853

13706

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

37.9

2038

15350

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.6

37.7

218

844

S29

ICPC

Skin symptom/complaint other

1.4

37.7

1957

14651

DMW00

NOMESCO Finland

Intubation of maxillary antrum

7.4

37.7

WVA30

NOMESCO Finland

Intramuscular and subcutaneous injection

4.7

37.4

188

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

37.3

717

4328

A04

ICPC

Weakness/tiredness general

1.4

37.3

1636

11884

R03BA05

ATC

fluticasone; inhalant

1.4

36.8

1799

13322

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

36.4

1834

13653

N17

ICPC

Vertigo/dizziness

1.5

36.3

1130

7661

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

36.1

402

2049

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

36.0

1055

7059

Z2221

NOMESCO Finland

Medical doctor

1.3

35.9

2593

20454

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.2

35.8

306

1412

D11

ICPC

Diarrhoea

1.5

35.7

1394

9899

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

35.5

1846

13809

A03

ICPC

Fever

1.4

35.4

2031

15446

R4130

NOMESCO Finland

Speech therapy

2.4

35.4

240

1003

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

35.3

1764

13106

R01AD58

ATC

fluticasone, combinations; nasal

1.3

35.1

2874

23080

W0X00

NOMESCO Finland

Estimation of continuous need for medical therapy

10.3

35.1

Z29.0

ICD-10 Finland

Isolation

8.2

35.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

34.9

2215

17118

A02BC05

ATC

esomeprazole; systemic

1.3

34.7

3665

30472

J20

ICD-10 Finland

Acute bronchitis

1.5

34.7

1035

6951

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

33.9

1280

9022

R51.80

ICD-10 Finland

Headache

1.4

33.9

1734

12925

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

33.6

739

4619

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

33.4

291

1353

SPAT1262

SPAT

Handing over of treatment supplies

1.5

33.3

1308

9290

R21

ICPC

Throat symptom/complaint

1.3

33.1

2711

21737

B01AB10

ATC

tinzaparin; parenteral

1.6

33.0

923

6109

SCC01

NOMESCO Finland

Fluoride application or other respective small prophylactic procedure

2.0

32.8

353

1778

A28

ICPC

Limited function/disability NOS

1.5

32.3

1114

7708

UJF32

NOMESCO Finland

Coloscopy

1.4

32.1

2038

15722

EB1AA, ,

SPAT

1.7

32.0

651

3988

TPH10

NOMESCO Finland

Sclerotherapy of varicose veins

3.8

31.5

255

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

31.1

708

4461

WZC30

NOMESCO Finland

Teaching

1.4

30.8

1384

10071

R03BA02

ATC

budesonide; inhalant

1.4

30.5

1691

12755

A11

ICPC

Chest pain NOS

1.6

30.3

697

4403

U13

ICPC

Bladder symptom/complaint other

2.2

30.3

265

1235

A10BH05

ATC

linagliptin; oral

2.0

30.2

330

1671

J01AA02

ATC

doxycycline; systemic

1.3

30.1

7529

69071

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

30.1

781

5079

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.5

30.0

924

6240

H04AA01

ATC

glucagon; nasal, parenteral

2.1

30.0

279

1332

R03BB04

ATC

tiotropium bromide; inhalant

1.6

30.0

670

4203

N02BE01

ATC

paracetamol; systemic, rectal

1.4

29.7

9325

88078

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

29.7

2591

20909

R05

ICD-10 Finland

Cough

1.3

29.6

2047

15975

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

5.3

29.4

109

N05CF01

ATC

zopiclone; oral

1.3

29.1

2593

20974

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

28.4

486

2839

B01AF02

ATC

apixaban; oral

1.5

28.0

812

5413

A02BC01

ATC

omeprazole; systemic

1.3

27.8

2283

18243

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

27.6

427

2424

ZX100

NOMESCO Finland

Oral

3.0

27.4

124

423

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

27.3

846

5717

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

4.9

27.3

124

L17

ICPC

Foot/toe symptom/complaint

1.3

27.3

2831

23324

Z3226

NOMESCO Finland

Physiotherapist

1.4

27.2

1498

11266

R96

ICPC

Asthma

1.5

27.2

880

6002

A01

ICPC

Pain general/multiple sites

1.5

27.2

888

6069

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

27.2

683

4406

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

27.1

892

6105

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

27.0

2795

23018

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.8

26.9

131

465

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.7

26.9

142

526

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

26.9

670

4314

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

26.9

2656

21741

X23

ICPC

Fear sexually transm dis female

1.5

26.8

777

5176

XA410

NOMESCO Finland

BAEP

7.7

26.7

C08CA01

ATC

amlodipine; oral

1.3

26.4

2645

21679

XKD00

NOMESCO Finland

Uroflowmetry

1.5

26.4

929

6445

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

26.3

1733

13400

H25.8

ICD-10 Finland

Other senile cataract

1.6

26.3

604

3813

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

26.1

1653

12702

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

3.0

26.1

115

387

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.9

26.0

308

1605

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

25.8

731

4845

O70.0

ICD-10 Finland

First degree perineal laceration during delivery

2.7

25.8

134

493

F29

ICPC

Eye symptom/complaint other

1.5

25.7

1014

7190

D82

ICPC

Teeth/gum disease

0.8

25.6

3001

35478

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.0

25.3

268

1344

A10BH01

ATC

sitagliptin; oral

1.6

25.2

619

3971

J01FA06

ATC

roxithromycin; oral

1.3

24.9

3513

29954

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.7

24.9

135

508

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

24.5

274

1400

S06.0

ICD-10 Finland

Concussion

1.4

24.4

1010

7222

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

24.2

444

2644

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

24.1

624

4054

A10BK01

ATC

dapagliflozin; oral

1.6

24.0

559

3539

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

23.9

607

3925

UKC02

NOMESCO Finland

Cystoscopy

1.4

23.9

1024

7371

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

23.7

1503

11541

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

23.7

1061

7697

R4110, ,

SPAT

0.6

23.5

507

7918

ZXA00

NOMESCO Finland

Right side

1.3

23.2

1890

15038

UDC00

NOMESCO Finland

Ear microscopy

1.6

23.2

632

4153

R07.3

ICD-10 Finland

Other chest pain

1.5

23.1

858

6009

A07AA02

ATC

nystatin; oral

1.7

23.1

420

2495

R00.2

ICD-10 Finland

Palpitations

1.5

23.0

785

5408

R31

ICPC

Respiratory, Medical examin/health eval partial

5.9

23.0

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

23.0

1191

8855

SPAT1053

SPAT

Memory test

1.5

23.0

716

4843

XQ800

NOMESCO Finland

Prick test

1.5

23.0

762

5221

R29

ICPC

Respiratory symptom/complaint other

1.5

22.9

645

4268

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

22.9

2299

18795

N30.0

ICD-10 Finland

Acute cystitis

1.3

22.9

1638

12799

N01

ICPC

Headache

1.4

22.7

1370

10437

C01CA24

ATC

epinephrine; parenteral

1.5

22.6

646

4287

N06AB04

ATC

citalopram; systemic

1.3

22.6

1776

14057

R31

ICD-10 Finland

Unspecified haematuria

1.5

22.4

657

4386

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

22.4

353

2016

H02AB07

ATC

prednisone; oral

1.4

22.2

1031

7521

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

22.0

204

975

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

21.9

763

5277

O70.1

ICD-10 Finland

Second degree perineal laceration during delivery

1.8

21.9

325

1823

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.2

21.7

262

N06AA12

ATC

doxepin; systemic

1.8

21.6

346

1986

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

21.6

285

1542

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.9

21.5

252

1310

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

21.4

479

3004

J05AB11

ATC

valaciclovir; oral

1.4

21.3

1296

9878

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

21.2

2042

16589

U07

ICPC

Urine symptom/complaint other

1.5

21.2

676

4594

QBB99

NOMESCO Finland

Other procedure for wound of skin of trunk

5.4

21.1

A05

ICPC

Feeling ill

1.5

21.1

726

5008

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.8

21.1

289

1581

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

21.0

235

1202

R11

ICD-10 Finland

Nausea and vomiting

1.5

21.0

809

5707

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

20.9

1180

8888

Catheterization and pressure measurement of the left side of the heart

2.9

20.9

331

EC1VA, ,

NOMESCO Finland

0.4

20.9

122

2851

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

20.8

641

4326

SPAT1310

SPAT

Counselling related to known health issue

0.8

20.6

2051

24868

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.5

20.6

190

3761

U02

ICPC

Urinary frequency/urgency

1.3

20.5

1316

10109

B01AB05

ATC

enoxaparin; parenteral

1.3

20.4

2436

20298

H02AB06

ATC

prednisolone; systemic

1.2

20.3

4229

37346

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

20.3

5373

48545

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

2.7

20.3

107

398

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

20.2

349

2045

EB1B, ,

NOMESCO Finland

32.6

20.1

N06AX11

ATC

mirtazapine; oral

1.2

20.1

3154

27063

R03BA08

ATC

ciclesonide; inhalant

1.5

20.1

770

5424

67009

ICD-8 Finland

Sepsis of childbirth and the puerperium, Unspecified

5.1

20.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

20.0

381

2295

A10BJ06

ATC

semaglutide; parenteral

1.6

19.9

416

2566

C03CA01

ATC

furosemide; systemic

1.3

19.9

1698

13569

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.7

19.9

381

2298

N05AH04

ATC

quetiapine; oral

1.3

19.9

1758

14115

B34.9

ICD-10 Finland

Viral infection, unspecified

1.8

19.7

323

1865

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

19.6

374

2253

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

19.5

3749

32810

WX110, ,

SPAT

1.5

19.5

556

3690

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

19.4

7174

66744

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

19.2

539

3563

SPAT1167

SPAT

Insertion of urinary catheter

2.1

19.2

179

858

SCA01

NOMESCO Finland

Preventive oral health care, short

0.8

19.2

2309

27432

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

19.1

695

4847

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

19.1

866

6288

R03DC03

ATC

montelukast; oral

1.3

19.1

1556

12354

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

19.0

1093

8252

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.1

19.0

186

908

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

19.0

1214

9315

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

18.9

1103

8347

R55

ICD-10 Finland

Syncope and collapse

1.4

18.8

794

5694

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

18.6

693

4853

EB1TW

NOMESCO Finland

3D modelling of dentition

4.6

18.6

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

18.6

1625

13017

J01MA14

ATC

moxifloxacin; systemic

1.5

18.6

667

4641

P01AB01

ATC

metronidazole; oral, rectal

1.2

18.6

3749

32929

R33

ICD-10 Finland

Retention of urine

1.6

18.5

455

2919

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

18.5

590

4009

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

18.4

4048

35827

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

18.4

555

3727

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

18.3

452

2903

K30

ICD-10 Finland

Functional dyspepsia

1.4

18.3

1031

7759

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

18.3

520

3449

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.3

18.3

1233

9533

RD211, ,

NOMESCO Finland

0.4

18.2

2107

QXA05

NOMESCO Finland

Skin division, unspecified location

4.2

18.1

116

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

18.0

1098

8360

D10

ICPC

Vomiting

1.4

18.0

720

5113

N05BA04

ATC

oxazepam; oral

1.2

18.0

2331

19559

W19

ICD-10 Finland

Unspecified fall

1.4

18.0

804

5824

J01CA04

ATC

amoxicillin; systemic

1.2

17.9

8858

84386

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

17.9

159

749

WX002

NOMESCO Finland

Sedation and analgesia

1.3

17.9

1390

10961

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

17.8

417

2645

N06AB06

ATC

sertraline; oral

1.3

17.8

1144

8779

E66

ICD-10 Finland

Obesity

1.5

17.8

578

3942

M79.6

ICD-10 Finland

Pain in limb

1.2

17.8

4213

37512

XQ802

NOMESCO Finland

Epicutan test

1.6

17.8

392

2451

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

3.3

17.5

198

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

17.5

195

998

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

17.5

2682

22895

WZC30, ,

SPAT

0.6

17.5

302

4983

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

2.5

17.5

110

447

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.2

17.4

144

659

OAB50, ,

SPAT

0.6

17.4

248

4300

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

17.4

871

6432

Z12.4

ICD-10 Finland

Special screening examination for neoplasm of cervix

0.3

17.3

1798

N02AX02

ATC

tramadol; systemic, rectal

1.2

17.2

3562

31298

A46

ICD-10 Finland

Erysipelas

1.4

17.2

1008

7628

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.5

17.2

159

3142

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

17.2

781

5673

R74

ICPC

Upper respiratory infection acute

1.2

17.0

3879

34375

C07AB07

ATC

bisoprolol; oral

1.2

17.0

3425

30013

LDA00

NOMESCO Finland

Dilatation of cervix uteri

2.8

17.0

286

R03AC03

ATC

terbutaline; inhalant

1.3

16.8

1194

9296

R52.9

ICD-10 Finland

Pain, unspecified

1.4

16.7

915

6852

J02AC01

ATC

fluconazole; systemic

1.2

16.7

3894

34568

R03AC13

ATC

formoterol; inhalant

1.6

16.7

364

2272

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

16.6

478

3179

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

2.8

16.5

296

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.7

16.5

276

1606

SPAT1368

SPAT

Periodic check-up in occupational healthcare

0.2

16.3

1152

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

2.3

16.3

116

498

G47.3

ICD-10 Finland

Sleep apnoea

1.3

16.3

1863

15391

WW500

NOMESCO Finland

Blood transfusion

1.7

16.3

285

1678

ZB0.0

ICD-10 Finland

Left side

15.3

16.1

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

16.1

688

4943

IHZ08, ,

SPAT

4.0

16.1

109

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

16.1

1274

10064

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

16.0

257

1478

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

2.5

15.8

390

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

15.8

1033

7945

J01EA01

ATC

trimethoprim; systemic

1.2

15.8

2208

18644

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

15.8

2004

16749

W90

ICPC

Uncompl labour/delivery livebirth

0.6

15.8

245

4152

WVA30, ,

SPAT

0.5

15.7

188

3428

S80.0

ICD-10 Finland

Contusion of knee

1.4

15.7

728

5303

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.2

15.7

131

602

Y94.8

ICD-10 Finland

Other leisure activity accident

1.8

15.6

236

1334

-1, ,

ICD-10 Finland

1.5

15.6

531

3657

J46

ICD-10 Finland

Status asthmaticus

1.8

15.6

234

1320

TGC00

NOMESCO Finland

Bronchial lavation

2.0

15.6

165

831

XCH00

NOMESCO Finland

Eye pressure measurement

1.6

15.5

326

2018

J35.0

ICD-10 Finland

Chronic tonsillitis

1.4

15.4

596

4204

B34.2

ICD-10 Finland

Coronavirus infection, unspecified site

2.6

15.4

354

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.7

15.3

298

1807

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

15.3

415

2725

ZXH09, ,

SPAT

0.3

15.3

1420

AA1AD

NOMESCO Finland

CT of head and brain

1.2

15.3

2009

16847

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

15.2

559

3906

XLA10, ,

NOMESCO Finland

1.6

15.1

377

2430

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.7

15.1

276

1647

X58

ICD-10 Finland

Exposure to other specified factors

1.3

15.1

1394

11226

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

15.1

958

7337

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

15.1

864

6516

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

14.9

147

721

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

14.9

2860

24882

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

14.8

122

559

J05AB01

ATC

aciclovir; systemic

1.2

14.8

1902

15906

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

14.7

410

2708

E66.01

ICD-10 Finland

Obesity due to excess calories

1.3

14.7

972

7487

G04CA02

ATC

tamsulosin; oral

1.3

14.7

1220

9693

A10BK03

ATC

empagliflozin; oral

1.4

14.6

660

4787

SPAT1098

SPAT

Exercise ECG

2.1

14.6

133

634

-44

ICPC

Preventive immunization/medic

0.6

14.5

247

4091

F01.2

ICD-10 Finland

Subcortical vascular dementia

5.1

14.5

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.2

14.5

1788

14877

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

14.5

5498

50617

A10BJ02

ATC

liraglutide; parenteral

1.8

14.5

229

1313

SPAT1255

SPAT

Intravenous administration of medicine

1.5

14.4

465

3167

R4120

NOMESCO Finland

Occupational therapy

1.5

14.4

513

3563

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

14.4

745

5526

C09CA06

ATC

candesartan; oral

1.2

14.3

1965

16537

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.5

14.3

431

2895

R95

ICPC

Chron obstructive pulmonary disease

1.9

14.3

167

870

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.5

14.3

411

2734

K01.16

ICD-10 Finland

Retained molar with obstruction in the upper jaw

1.9

14.3

183

984

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

14.3

542

3813

R81

ICPC

Pneumonia

1.7

14.2

284

1734

J01MA12

ATC

levofloxacin; systemic

1.3

14.2

1283

10300

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

14.2

1132

8945

207

Kela drug reimbursment

Chronic arrhythmias

1.4

14.2

799

6009

A06AD11

ATC

lactulose; oral

1.3

14.2

894

6839

R4190

NOMESCO Finland

Nutritional therapy

1.6

14.1

347

2229

K07

ICPC

Swollen ankles/oedema

1.7

14.1

281

1715

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.2

14.1

118

544

QBA00

NOMESCO Finland

Puncture of skin of trunk

4.2

14.1

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

14.1

331

2106

SPAT1387

SPAT

Health survey during first study year, university level

1.9

14.0

178

954

ZYB04, ,

SPAT

3.3

14.0

159

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

2.7

14.0

277

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

13.9

780

5862

R13

ICD-10 Finland

Dysphagia

1.5

13.9

495

3440

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

13.8

558

3968

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

6.0

13.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

13.8

463

3180

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.9

13.7

162

848

L04AD02

ATC

tacrolimus; systemic

2.4

13.6

357

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.2

13.6

112

513

D06BB10

ATC

imiquimod; topical

1.5

13.6

423

2862

J18

ICD-10 Finland

Pneumonia, organism unspecified

2.4

13.6

382

SPAT1377

SPAT

Polysomnography

0.4

13.4

1506

N18.8

ICD-10 Finland

Other chronic renal failure

2.0

13.4

135

669

R52.0

ICD-10 Finland

Acute pain

1.6

13.3

298

1873

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

13.3

1015

7968

WX721

NOMESCO Finland

Oxygen concentrator therapy

6.3

13.3

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

13.2

797

6053

R04.2

ICD-10 Finland

Haemoptysis

1.8

13.2

204

1162

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

13.2

2342

20199

M01AB05

ATC

diclofenac; systemic, rectal

1.2

13.1

6188

57724

MATER, ,

NOMESCO Finland

40.1

13.1

M03BX02

ATC

tizanidine; oral

1.2

13.1

6052

56373

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

13.0

2367

20456

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

12.9

410

2785

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

12.9

1804

15199

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

12.9

1047

8290

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

12.9

500

3533

127

Kela drug reimbursment

Transplant complication

2.1

12.8

115

546

R01AD08

ATC

fluticasone; nasal

1.2

12.8

2677

23419

E66.8

ICD-10 Finland

Other obesity

1.4

12.8

538

3857

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.3

12.7

859

6632

I10

ICD-10 Finland

Essential (primary) hypertension

1.2

12.7

4321

39298

N02AA05

ATC

oxycodone; systemic

1.3

12.7

1099

8772

D06

ICPC

Abdominal pain localized other

1.3

12.7

851

6567

WYA10

NOMESCO Finland

Emergency care or similar visit

1.4

12.6

670

4993

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

2.9

12.6

202

WE200

NOMESCO Finland

Profylactive therapy of malignancy with hormones

12.2

12.6

L04AA06

ATC

mycophenolic acid; systemic

1.9

12.6

144

747

W52

ICD-10 Finland

Crushed, pushed or stepped on by crowd or human stampede

1.9

12.6

163

881

A10AC01

ATC

insulin (human); parenteral

1.4

12.5

533

3827

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

12.5

214

1256

S09.9

ICD-10 Finland

Unspecified injury of head

2.1

12.5

122

598

ZXH06, ,

SPAT

0.5

12.4

147

2685

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

2.7

12.4

231

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

3.2

12.4

156

J01CA08

ATC

pivmecillinam; oral

1.2

12.4

3920

35437

J01FF01

ATC

clindamycin; systemic

1.2

12.4

2232

19258

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

1.4

12.4

473

3332

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

12.4

599

4398

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

1.9

12.3

145

759

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

12.3

857

6645

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.5

12.3

122

A10BB12

ATC

glimepiride; oral

1.6

12.3

308

1990

TQW40, ,

SPAT

0.7

12.3

428

6077

A10BG03

ATC

pioglitazone; oral

1.9

12.2

143

747

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

1.9

12.2

155

833

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.9

12.2

147

777

J01

ICD-10 Finland

Acute sinusitis

1.4

12.1

562

4098

OAB47, ,

SPAT

1.4

12.1

559

4074

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

0.7

12.1

445

6255

TDA90, ,

SPAT

0.6

12.1

200

3329

K58

ICD-10 Finland

Irritable bowel syndrome

1.6

12.0

260

1622

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

12.0

834

6463

M79.1

ICD-10 Finland

Myalgia

1.2

12.0

1410

11660

N06AB10

ATC

escitalopram; oral

1.2

11.9

2121

18270

R03AC12

ATC

salmeterol; inhalant

1.6

11.9

275

1743

H01

ICPC

Ear pain/earache

1.3

11.9

1193

9690

B37.08

ICD-10 Finland

Other candidal stomatitis

2.5

11.9

289

I95.1

ICD-10 Finland

Orthostatic hypotension

1.7

11.8

194

1126

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

11.8

713

5417

H02.3

ICD-10 Finland

Blepharochalasis

1.5

11.7

408

2824

V03AE01

ATC

polystyrene sulfonate; oral

2.5

11.7

297

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.0

11.7

117

579

K07.60

ICD-10 Finland

Snapping jaw

1.4

11.7

518

3748

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

2.1

11.6

102

481

K07.13

ICD-10 Finland

Retrognaty, mandibular

1.9

11.6

139

733

S04

ICPC

Lump/swelling localized

1.3

11.6

998

7958

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

11.6

800

6197

ZX120

NOMESCO Finland

Intravenous

1.3

11.5

650

4889

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.5

11.5

359

2432

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

1.8

11.5

162

899

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

11.5

204

1210

N03AX16

ATC

[U] pregabalin

1.2

11.5

1713

14509

R73

ICD-10 Finland

Elevated blood glucose level

1.7

11.5

213

1279

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

11.5

247

SPAT1389

SPAT

Visit based on need for special support

1.6

11.4

277

1777

SPAT1379

SPAT

Health check-up of pregnant person

0.8

11.4

798

10182

R06AX27

ATC

desloratadine; oral

1.2

11.4

2993

26632

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

11.4

1348

11149

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

11.4

171

968

KMAK, ,

NOMESCO Finland

1.1

11.4

5127

47459

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

1.8

11.4

166

932

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.3

11.3

370

H3600, E103,

ICD-10 Finland

2.1

11.3

108

526

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

11.3

615

4601

L12

ICPC

Hand/finger symptom/complaint

1.2

11.3

1573

13234

ZZC10

NOMESCO Finland

Allograft of fascia

15.0

11.3

SPAT1281

SPAT

Other administrative function

0.7

11.2

318

4695

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.9

11.2

131

685

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

11.2

428

3016

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

0.4

11.2

1254

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

11.2

467

3346

XA800

NOMESCO Finland

Neuropsychological investigation

1.5

11.2

327

2188

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

11.1

442

3137

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

1.9

11.1

127

660

Z94.0

ICD-10 Finland

Kidney transplant status

2.3

11.1

367

H57.1

ICD-10 Finland

Ocular pain

1.5

11.1

362

2477

-48

ICPC

Clarification/discussion RFE/demand

0.5

11.0

1628

U01

ICPC

Dysuria/painful urination

1.3

11.0

702

5378

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

10.9

896

7098

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

2.3

10.9

369

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.6

10.9

263

1685

WX723

NOMESCO Finland

CPAP therapy

0.5

10.9

125

2302

EMB10

NOMESCO Finland

Tonsillectomy

1.3

10.9

628

4739

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

10.9

1387

11558

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

10.9

7698

73411

R07.0

ICD-10 Finland

Pain in throat

1.3

10.9

752

5825

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

10.9

521

3821

R03AK08

ATC

formoterol and beclometasone; inhalant

1.5

10.8

339

2299

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

10.8

378

2620

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

10.8

4560

41965

WX720

NOMESCO Finland

Own respiration

1.5

10.8

356

2441

K02

ICD-10 Finland

Dental caries

0.7

10.8

299

4431

H81

ICPC

Excessive ear wax

1.2

10.7

1181

9692

FP1E5

NOMESCO Finland

ECG, with computer analysis

17.8

10.7

B01AC04

ATC

clopidogrel; oral

1.3

10.7

845

6664

R35

ICD-10 Finland

Polyuria

1.4

10.7

439

3136

M01AC01

ATC

piroxicam; systemic, rectal

1.3

10.6

817

6419

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.4

10.6

1181

J01CA02

ATC

pivampicillin; oral

1.6

10.6

263

1697

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

2.5

10.6

251

SPAT1360

SPAT

Extensive global examination

1.4

10.6

481

3497

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

0.6

10.6

138

2445

XA420

NOMESCO Finland

Extensive sleep examination

2.3

10.6

343

C01DA14

ATC

isosorbide mononitrate; oral

1.3

10.5

683

5244

C07AB02

ATC

metoprolol; systemic

1.2

10.5

1152

9444

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

10.5

449

3228

SPAT1131

SPAT

Colonoscopy

0.4

10.5

1220

N18.0

ICD-10 Finland

End-stage renal disease

2.5

10.5

252

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

10.5

7503

71493

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.3

10.5

882

7011

SPAT1097

SPAT

Recording of ECG

1.3

10.5

904

7209

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.3

10.5

1091

8897

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.3

10.5

332

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

10.5

307

2056

D12

ICPC

Constipation

1.6

10.5

254

1632

M53.2

ICD-10 Finland

Spinal instabilities

2.4

10.4

283

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.3

10.4

657

5027

UJH02

NOMESCO Finland

Anoscopy

1.5

10.4

280

1842

F03

ICD-10 Finland

Unspecified dementia

1.7

10.4

165

951

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

10.4

1801

15465

MA3AE, ,

SPAT

0.2

10.3

437

R52.2

ICD-10 Finland

Other chronic pain

1.5

10.3

285

1885

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

10.3

629

4789

SPAT1283

SPAT

Restricted health certificate

1.2

10.3

2057

17884

A10AB01

ATC

insulin (human); parenteral

1.5

10.2

271

1776

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.2

10.2

393

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

10.2

134

729

SPAT1249

SPAT

Treatment-related counselling outside office

0.9

10.2

2988

33187

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.7

10.2

181

1076

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.4

10.2

489

3589

Z13.88

ICD-10 Finland

Special screening examination for other specified diseases and disorders

1.8

10.2

133

723

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.8

10.2

152

861

SPAT1104

SPAT

Monitoring of emergency patient

0.6

10.1

199

3175

C10AA05

ATC

atorvastatin; oral

1.2

10.1

2757

24566

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.3

10.1

652

5004

G44.2

ICD-10 Finland

Tension-type headache

1.2

10.1

1270

10570

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.8

10.1

136

747

F01

ICD-10 Finland

Vascular dementia

5.0

10.0

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

10.0

409

2921

A10AB04

ATC

insulin lispro; parenteral

1.6

10.0

249

1610

ZX108

NOMESCO Finland

Inhalation

2.7

10.0

200

-31

ICPC

Medical examin/health eval partial

0.7

10.0

245

3720

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

2.2

10.0

352

R10.0

ICD-10 Finland

Acute abdomen

1.5

9.9

261

1707

B99

ICD-10 Finland

Other and unspecified infectious diseases

1.9

9.9

125

671

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

9.9

310

2103

A10BX02

ATC

repaglinide; oral

2.3

9.9

296

AN1

Coronary angiography

1.4

9.9

513

3811

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.4

9.9

360

2517

M05BX04

ATC

denosumab; parenteral

1.5

9.9

332

2286

ZXD20

NOMESCO Finland

Day surgery

1.3

9.9

957

7740

B03XA02

ATC

darbepoetin alfa; parenteral

1.9

9.8

120

638

J01MA06

ATC

norfloxacin; oral

1.3

9.8

896

7196

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.4

9.8

390

2772

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.8

977

7928

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.6

9.7

239

1542

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.7

9.7

186

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.4

9.7

486

3593

H92.0

ICD-10 Finland

Otalgia

1.3

9.7

611

4676

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.9

9.7

108

558

TI02, ,

NOMESCO Finland

55.0

9.6

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.8

9.6

723

9144

G01AA10

ATC

clindamycin; vaginal

1.2

9.6

1259

10522

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.6

9.6

201

1249

KH2AD

NOMESCO Finland

Computed tomography examination of urinary tract stones

5.0

9.6

K08.3

ICD-10 Finland

Retained dental root

1.3

9.5

527

3954

J96.1

ICD-10 Finland

Chronic respiratory failure

2.0

9.5

101

512

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

9.5

442

3226

SPAT1181

SPAT

Ultrasound examination of uterus and uterine appendages

1.5

9.5

287

1936

D07AB01

ATC

clobetasone; topical

1.6

9.5

228

1463

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.1

9.5

412

A10AA01, ,

ATC

1.6

9.5

200

1244

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

9.5

215

1361

S01.8

ICD-10 Finland

Open wound of other parts of head

1.9

9.5

116

618

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.2

9.5

1088

8967

Z20.2

ICD-10 Finland

Contact with and exposure to infections with a predominantly sexual mode of transmission

0.5

9.4

1855

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

9.4

198

1230

MA5AE, ,

SPAT

0.2

9.4

454

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

9.4

1940

16893

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.4

9.4

272

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

9.4

3415

31027

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

2.7

9.4

189

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.8

9.4

161

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

9.4

498

3716

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.2

9.3

349

R06AE07

ATC

cetirizine; oral

1.1

9.3

4302

39708

L15

ICPC

Knee symptom/complaint

1.2

9.3

2114

18556

G90.8

ICD-10 Finland

Other disorders of autonomic nervous system

4.5

9.3

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.5

9.3

289

1962

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.6

9.2

230

1488

Z23.5

ICD-10 Finland

Need for immunization against tetanus alone

0.2

9.2

431

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

9.2

488

3638

F43.0

ICD-10 Finland

Acute stress reaction

1.3

9.2

630

4877

177

Kela drug reimbursment

Insulin glargine 300 U / ml

1.8

9.2

142

813

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

9.2

191

1184

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.5

9.2

270

1811

F17

ICPC

Glasses symptom/complaint

2.2

9.2

345

FM1AD

NOMESCO Finland

CT of heart

3.5

9.2

A27

ICPC

Fear of other disease NOS

1.4

9.2

364

2588

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

2.5

9.1

227

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.3

9.1

301

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

9.1

854

6879

H66.9

ICD-10 Finland

Otitis media, unspecified

1.3

9.1

688

5396

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.2

9.1

1685

14543

HAB99

NOMESCO Finland

Other partial excision of mammary gland

1.7

9.0

159

944

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

9.0

308

2130

Z01.2

ICD-10 Finland

Dental examination

1.1

9.0

4823

44899

N02BF02

ATC

pregabalin; oral

1.3

9.0

520

3930

H53.1

ICD-10 Finland

Subjective visual disturbances

1.3

9.0

556

4245

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

9.0

3966

36479

I20.09

ICD-10 Finland

Unstable angina

1.5

8.9

265

1781

K25

ICPC

Fear of hypertension

1.5

8.9

245

1620

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

0.2

8.9

682

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.6

8.9

183

L05

ICPC

Flank/axilla symptom/complaint

1.4

8.9

478

3573

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

8.9

1202

10072

FL1AC

NOMESCO Finland

Left cardioangiography

2.1

8.9

416

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

8.9

694

5468

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

4.3

8.8

N06AX21

ATC

duloxetine; oral

1.2

8.8

1002

8246

R053, ,

ICD-10 Finland

1.5

8.8

300

2073

LX2A3, ,

SPAT

0.6

8.8

138

2322

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

0.7

8.8

293

4188

T89

ICPC

Diabetes insulin dependent

1.4

8.8

325

2282

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

8.7

292

2011

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

1.6

8.7

195

1231

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.2

8.7

1158

9686

Y25

ICPC

Fear sexually transm disease male

1.6

8.7

204

1303

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.4

8.7

464

3466

W12

ICPC

Contraception intrauterine

1.2

8.7

1155

9663

M01AE02

ATC

naproxen; oral, rectal

1.1

8.7

5555

52228

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.7

8.6

141

821

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

2.9

8.6

130

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

8.6

2390

21285

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

1.4

8.6

351

2508

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

3.4

8.6

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.2

8.6

322

D18

ICPC

Change in faeces/bowel movements

1.6

8.6

197

1253

K57

ICD-10 Finland

Diverticular disease of intestine

1.7

8.5

138

801

NBE25

NOMESCO Finland

Suture or reinsertion of ligament of shoulder, arthroscopic

2.7

8.5

164

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.4

8.5

229

M01AB08

ATC

etodolac; oral

1.3

8.5

470

3529

XQ848

NOMESCO Finland

Dermatological photography

1.6

8.5

204

1310

A11CC03

ATC

alfacalcidol; systemic

1.7

8.5

141

825

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

8.5

1735

15090

N06AA10

ATC

nortriptyline; systemic

1.7

8.4

148

879

TK800

NOMESCO Finland

Hemodialysis

1.8

8.4

122

686

A12AA04

ATC

calcium carbonate; oral

2.0

8.4

445

171

Kela drug reimbursment

Degludekinsuliini

2.9

8.4

132

G04BD12

ATC

mirabegron; oral

1.3

8.4

699

5551

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

8.4

232

1538

C03DA01

ATC

spironolactone; oral

1.3

8.4

708

5633

V03AE03

ATC

lanthanum carbonate; oral

3.1

8.4

111

D05AX52

ATC

calcipotriol, combinations; topical

1.4

8.4

372

2699

R05FB02

ATC

cough suppressants and expectorants; systemic

1.1

8.4

2737

24656

U71

ICPC

Cystitis/urinary infection other

1.3

8.4

551

4245

L23.4

ICD-10 Finland

Allergic contact dermatitis due to dyes

4.5

8.3

SPAT1337

SPAT

Booking of telephone appointment

4.9

8.3

A10AA02, ,

ATC

1.5

8.3

215

1404

N05AA02

ATC

levomepromazine; systemic

1.5

8.3

262

1784

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

3.2

8.3

SAB02

NOMESCO Finland

Oral and dental health check by dental hygienist or dental assistant

0.7

8.3

431

5727

A97

ICPC

No disease

1.2

8.3

1741

15175

J30.3

ICD-10 Finland

Other allergic rhinitis

1.4

8.3

324

2300

R07.1

ICD-10 Finland

Chest pain on breathing

1.8

8.2

122

691

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

8.2

414

3066

U05

ICPC

Urination problems other

1.4

8.2

316

2236

L57.0

ICD-10 Finland

Actinic keratosis

1.3

8.2

532

4091

R5599

NOMESCO Finland

Other rehabilitation service

1.6

8.2

197

1267

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

2.1

8.2

329

EB4VA, ,

NOMESCO Finland

0.8

8.2

1296

15152

L14

ICPC

Leg/thigh symptom/complaint

1.3

8.1

601

4701

WX892

NOMESCO Finland

Monitored bed care

1.3

8.1

473

3579

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.5

8.1

259

1768

MBC10

NOMESCO Finland

Repair of obstetric laceration of vagina

0.5

8.1

1456

WX111

NOMESCO Finland

Local infiltration anesthesia

1.6

8.1

199

1285

SAA04

NOMESCO Finland

Special examination of mouth

1.4

8.1

419

3116

J01FA10

ATC

azithromycin; systemic

1.1

8.1

5920

55996

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

1.8

8.1

104

565

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

8.1

404

2989

SMAK, ,

NOMESCO Finland

2.3

8.1

260

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.0

8.0

446

K92.1

ICD-10 Finland

Melaena

1.4

8.0

306

2162

XX1VW, ,

SPAT

2.2

8.0

312

SPF20

NOMESCO Finland

Temporary relining of dentures

2.3

8.0

242

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.6

8.0

166

1031

120

Kela drug reimbursment

Hypogammaglobulinaemia

4.1

8.0

U72

ICPC

Urethritis

1.6

8.0

185

1180

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.5

8.0

213

1403

R30.0

ICD-10 Finland

Dysuria

1.4

7.9

360

2621

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

7.9

179

1134

V19

ICD-10 Finland

Pedal cyclist injured in other and unspecified transport accidents

1.6

7.9

174

1095

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.4

7.9

351

2545

WX290, ,

SPAT

1.4

7.9

309

2192

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.5

7.9

226

1509

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

7.9

651

5163

R06AX13

ATC

loratadine; oral

1.2

7.9

1368

11725

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

7.9

415

3093

K10.3

ICD-10 Finland

Alveolitis of jaws

1.3

7.9

442

3327

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

7.9

488

3727

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.3

7.9

782

6342

SPAT1366

SPAT

Health check-up performed based on health survey in students of universities, universities of applied sciences etc.

1.4

7.9

305

2161

EB1A, ,

NOMESCO Finland

7.7

7.9

N19

ICD-10 Finland

Unspecified kidney failure

1.6

7.8

181

1153

S01XA18

ATC

ciclosporin; ophthalmic

2.2

7.8

283

ZXD40

NOMESCO Finland

Procedure on patient requiring isolation

3.3

7.8

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

7.8

281

1967

38402

ICD-8 Finland

Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita

2.1

7.8

356

K07.14

ICD-10 Finland

Retrognaty, maxillary

2.6

7.7

167

Y94.0

ICD-10 Finland

Accident at home

1.8

7.7

117

668

R1420

NOMESCO Finland

Assessment of rehabilitation needs and/or compilation of rehabilitation plan

3.6

7.7

R49.01

ICD-10 Finland

Functional dysphonia

1.5

7.7

211

1397

H53.2

ICD-10 Finland

Diplopia

1.5

7.7

209

1381

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.8

7.7

611

7674

WYA30, ,

SPAT

2.3

7.7

253

Z72.0

ICD-10 Finland

Tobacco use

1.5

7.7

207

1367

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

7.4

7.7

K04.08

ICD-10 Finland

Other specified pulpit

1.2

7.6

767

6228

SGC40

NOMESCO Finland

Preparing and restoring tooth to enable root canal treatment

1.6

7.6

180

1153

A10BJ05

ATC

dulaglutide; parenteral

1.7

7.6

123

715

Y59

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified vaccines and biological substances

2.1

7.6

345

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.2

7.6

286

E87.6

ICD-10 Finland

Hypokalaemia

1.5

7.6

199

1305

Z39.1

ICD-10 Finland

Care and examination of lactating mother

1.5

7.6

219

1466

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

7.6

235

1596

W49

ICD-10 Finland

Exposure to other and unspecified inanimate mechanical forces

1.7

7.6

133

791

TI01, ,

NOMESCO Finland

18.3

7.6

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.4

7.6

343

2497

N76.0

ICD-10 Finland

Acute vaginitis

1.3

7.6

736

5954

SPAT1301

SPAT

No procedures

1.1

7.6

2545

22942

W44

ICD-10 Finland

Foreign body entering into or through eye or natural orifice

1.7

7.6

126

739

H81.3

ICD-10 Finland

Other peripheral vertigo

1.6

7.6

178

1140

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.5

7.5

225

1517

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.4

7.5

199

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.4

7.5

385

2860

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

1.2

7.5

1053

8855

KED52

NOMESCO Finland

Visual laser resection of prostate

2.2

7.5

288

OAB42

NOMESCO Finland

Guidance related to known health problem

2.7

7.5

141

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

2.5

7.5

176

WGA11

NOMESCO Finland

Planning of pain management

2.4

7.5

194

W10

ICD-10 Finland

Fall on and from stairs and steps

1.4

7.5

373

2761

R03AK11

ATC

formoterol and fluticasone; inhalant

1.6

7.4

175

1121

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.4

7.4

276

1942

XCK00

NOMESCO Finland

Perimetry

1.4

7.4

360

2651

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.2

7.4

752

6113

CG2T4

NOMESCO Finland

Topography assessment of cornea

2.1

7.4

329

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.4

7.4

301

2153

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

2.2

7.4

270

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

7.4

335

2441

J01DB01

ATC

cefalexin; oral

1.1

7.4

8480

82111

R22.7

ICD-10 Finland

Localized swelling, mass and lump, multiple sites

3.3

7.4

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

7.3

320

2316

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

7.3

448

3420

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

1.2

7.3

1426

12349

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

7.3

413

3116

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.4

7.3

286

2033

OAB30

NOMESCO Finland

Breastfeeding and breast care guidance

10.8

7.3

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

1.7

7.3

112

643

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

1.9

7.3

434

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

7.3

1078

9113

TQB05

NOMESCO Finland

Puncture of skin of trunk

2.0

7.2

352

R60.0

ICD-10 Finland

Localized oedema

1.2

7.2

828

6822

TKC22

NOMESCO Finland

Catheterisation instruction

1.7

7.2

119

697

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.4

7.2

292

2088

K86.1

ICD-10 Finland

Other chronic pancreatitis

2.2

7.2

254

LAA06

NOMESCO Finland

Transvaginal puncture of ovarian cyst

2.1

7.2

293

RF210, ,

NOMESCO Finland

0.5

7.2

1356

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.1

3288

30213

A92

ICPC

Allergy/allergic reaction NOS

1.4

7.1

301

2167

EBA40

NOMESCO Finland

Extraction of apex of root of tooth

1.9

7.1

437

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

2.9

7.1

111

G01AF05

ATC

econazole; vaginal

1.3

7.1

578

4578

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

7.1

472

3642

C07AA05

ATC

propranolol; systemic

1.2

7.1

1804

15939

S16

ICPC

Bruise/contusion

1.5

7.1

200

1333

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.8

7.1

523

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

3.2

7.1

SCB02

NOMESCO Finland

Instructions for self-performed oral hygiene

2.9

7.1

106

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

1.7

7.1

118

693

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

2.2

7.1

262

G04CB02

ATC

dutasteride; oral

1.4

7.1

320

2331

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.4

7.1

846

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.6

7.1

150

2342

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.5

7.1

1376

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.4

7.0

290

2080

M54.8

ICD-10 Finland

Other dorsalgia

1.4

7.0

361

2684

TBA20

NOMESCO Finland

Aspiration cytology of thyroid gland

8.8

7.0

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.6

7.0

158

1002

D01AE16

ATC

amorolfine; topical

1.2

7.0

730

5952

D06BB03

ATC

aciclovir; topical

1.4

7.0

327

2394

R51

ICD-10 Finland

Headache

1.3

7.0

537

4223

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.6

7.0

161

1026

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

7.0

197

1313

A10BH02

ATC

vildagliptin; oral

1.8

7.0

511

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

3.6

7.0

TAB00

NOMESCO Finland

Lumbar puncture

1.4

7.0

340

2506

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.7

7.0

108

621

H29

ICPC

Ear symptom/complaint other

1.2

7.0

901

7515

O26.7

ICD-10 Finland

Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium

1.8

7.0

106

607

XX9TB

NOMESCO Finland

Complementary X-ray examination with contrast

3.9

7.0

SPAT1044

SPAT

Tympanometry

1.6

7.0

164

1052

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.3

6.9

587

4674

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.2

6.9

842

6980

O48

ICD-10 Finland

Prolonged pregnancy

0.6

6.9

160

2453

A41.8

ICD-10 Finland

Other specified sepsis

1.8

6.9

535

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

1.7

6.9

118

698

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

6.9

840

6964

F41.3

ICD-10 Finland

Other mixed anxiety disorders

1.5

6.9

173

1125

ZYC01, ,

SPAT

0.8

6.9

712

8682

PD4HE

NOMESCO Finland

Postoperative lower extremity artery ultrasound examination with Doppler method

5.8

6.9

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

1.5

6.9

181

1190

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.5

6.9

222

1523

WX704

NOMESCO Finland

Intubation

1.3

6.9

600

4797

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

6.9

431

3302

C07AG02

ATC

carvedilol; oral

1.4

6.9

281

2014

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

6.9

198

1328

M54

ICD-10 Finland

Dorsalgia

1.2

6.8

1137

9709

I50.0

ICD-10 Finland

Congestive heart failure

1.4

6.8

291

2099

SPAT1058

SPAT

PEF monitoring instruction

1.3

6.8

550

4353

S18

ICPC

Laceration/cut

1.1

6.8

3883

36091

M02AA07

ATC

piroxicam; topical

1.1

6.8

2516

22796

S33.5

ICD-10 Finland

Sprain and strain of lumbar spine

1.8

6.8

494

WE300

NOMESCO Finland

Profylactive therapy of malignancy with biomoidiers

8.2

6.8

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

6.8

320

2347

D64.8

ICD-10 Finland

Other specified anaemias

1.8

6.8

103

590

M03BC01

ATC

orphenadrine (citrate); systemic

1.1

6.8

1933

17220

205

Kela drug reimbursment

Chronic hypertension

1.2

6.8

1334

11557

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.5

6.8

176

1155

X14

ICPC

Vaginal discharge

1.4

6.7

257

1819

SCA02

NOMESCO Finland

Preventive oral health care

0.8

6.7

688

8398

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.4

6.7

287

2072

IHA10, ,

SPAT

0.5

6.7

1405

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.6

6.7

1443

A49

ICD-10 Finland

Bacterial infection of unspecified site

3.1

6.7

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.3

6.7

428

3288

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

6.7

641

5181

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.3

6.7

365

2741

EBA30

NOMESCO Finland

Extraction of root of tooth

1.3

6.7

363

2725

K96

ICPC

Haemorrhoids

1.4

6.7

241

1690

R03DA04

ATC

theophylline; systemic, rectal

1.4

6.6

245

1724

Z30.5

ICD-10 Finland

Surveillance of (intrauterine) contraceptive device

1.2

6.6

712

5827

-30

ICPC

Medical examin/health eval complete

0.7

6.6

168

2525

K03.00

ICD-10 Finland

Approximal wear

1.2

6.6

665

5403

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

2.3

6.6

199

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

2.8

6.6

116

GDG10

NOMESCO Finland

Bilateral transplantation of lung

7.8

6.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

6.6

430

3313

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.4

6.6

321

2369

J06.0

ICD-10 Finland

Acute laryngopharyngitis

1.8

6.6

551

J32.8

ICD-10 Finland

Other chronic sinusitis

2.4

6.6

181

G03DA02

ATC

medroxyprogesterone; systemic

1.3

6.6

503

3958

EBA10

NOMESCO Finland

Operative extraction of tooth

1.2

6.5

1430

12490

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.3

6.5

386

2932

D02

ICPC

Abdominal pain epigastric

1.3

6.5

512

4040

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.3

6.5

443

3431

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.4

6.5

319

2355

WX780

NOMESCO Finland

Remote monitoring CPAP

0.7

6.5

156

2372

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.6

6.5

156

1005

SPAT1189

SPAT

Other ultrasound examination during pregnancy

0.7

6.5

153

2335

EB1HA, ,

SPAT

1.5

6.5

204

1392

T82

ICPC

Obesity

1.3

6.5

373

2822

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.3

6.5

356

2675

A10AD05

ATC

insulin aspart; parenteral

1.9

6.5

423

J47

ICD-10 Finland

Bronchiectasis

1.8

6.5

495

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.5

6.5

152

L23.5

ICD-10 Finland

Allergic contact dermatitis due to other chemical products

1.9

6.5

374

Z5132

NOMESCO Finland

Nursing associate professional

2.2

6.5

220

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

6.5

128

788

X15

ICPC

Vaginal symptom/complaint other

1.3

6.5

425

3278

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

6.5

535

4251

VALMI, ,

NOMESCO Finland

1.1

6.5

2317

20950

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

3.6

6.5

CKC12

NOMESCO Finland

Photocoagulation of retina

1.4

6.5

257

1834

R51.81

ICD-10 Finland

Facial pain NOS

1.5

6.4

183

1224

V03AE02

ATC

sevelamer; oral

2.6

6.4

135

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1.6

6.4

127

782

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.1

6.4

260

B02AA02

ATC

tranexamic acid; systemic

1.2

6.4

1249

10812

F50.2

ICD-10 Finland

Bulimia nervosa

1.9

6.4

397

X57

ICD-10 Finland

Unspecified privation

1.5

6.4

159

1034

J03

ICD-10 Finland

Acute tonsillitis

1.4

6.4

283

2058

J16.8

ICD-10 Finland

Pneumonia due to other specified infectious organisms

3.7

6.3

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.1

6.3

288

E0000UV, ,

ATC

1.1

6.3

3880

36179

N05BA12

ATC

alprazolam; oral

1.2

6.3

690

5661

E87.5

ICD-10 Finland

Hyperkalaemia

1.8

6.3

478

C10AA07

ATC

rosuvastatin; oral

1.1

6.3

2368

21472

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.2

6.3

786

6537

F03

ICPC

Eye discharge

1.3

6.3

584

4707

I84

ICD-10 Finland

Hemorrhoids

1.5

6.3

171

1135

IER02, ,

SPAT

3.3

6.3

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

3.8

6.2

SBB10

NOMESCO Finland

Dental impressions

1.2

6.2

620

5033

N06AX12

ATC

bupropion; oral

1.2

6.2

735

6078

N30

ICD-10 Finland

Cystitis

1.2

6.2

740

6124

KAY20, ,

NOMESCO Finland

1.4

6.2

239

1696

R41.0

ICD-10 Finland

Disorientation, unspecified

1.6

6.2

143

914

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.4

6.2

241

1713

Z10.0

ICD-10 Finland

Occupational health examination

0.8

6.2

683

8272

OAB39, ,

SPAT

1.2

6.2

662

5416

WW200

NOMESCO Finland

Immunization

1.5

6.2

193

1316

K07.62

ICD-10 Finland

Habitual dislocation of the jaw joint

1.9

6.2

359

T18.1

ICD-10 Finland

Foreign body in oesophagus

2.0

6.2

304

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.4

6.2

214

1489

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.1

6.2

Z94.2

ICD-10 Finland

Lung transplant status

5.0

6.2

H01.9

ICD-10 Finland

Inflammation of eyelid, unspecified

1.6

6.2

135

853

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

1.5

6.2

165

1091

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.3

6.2

364

2768

QDA50

NOMESCO Finland

Cryotherapy of skin of lower limb

3.5

6.1

H02AB09

ATC

hydrocortisone; systemic

1.5

6.1

170

1132

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

6.1

767

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

6.1

332

2494

A08

ICPC

Swelling

1.3

6.1

335

2520

K07.24

ICD-10 Finland

Open bite

1.7

6.1

112

678

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

0.7

6.1

245

3379

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.0

6.1

334

H10.5

ICD-10 Finland

Blepharoconjunctivitis

1.5

6.1

152

991

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.4

6.1

309

2299

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.3

6.0

457

3592

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.4

6.0

292

2154

M05BA04

ATC

alendronic acid; oral

1.3

6.0

411

3188

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

1.4

6.0

234

1665

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.3

6.0

376

2883

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015736) pH of Urine

6240

42006

2.10

309.35

4.6

3.2

6.49

6.21

80.02

4068

23784

(3014051) Protein [Presence] in Urine by Test strip

5325

29177

2.57

307.65

4.4

2.6

0.02

0.06

1.67

239

460

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1483

3956

4.17

307.65

2.9

3.1

1.14

1.29

5.27

1471

3933

(3007930) Methemoglobin/Hemoglobin.total in Blood

1516

2844

6.01

307.65

3.5

5.3

0.82

0.89

9.45

1499

2662

(3014576) Chloride [Moles/volume] in Serum or Plasma

2697

10678

3.01

307.65

6.1

7.0

104.96

104.48

mmol/l

5.94

2692

10672

(3002032) Base excess in Venous blood by calculation

2818

7508

4.68

307.65

4.7

4.1

1.97

1.70

mmol/l

4.17

2458

6516

(3026782) Osmolality of Urine

3844

16463

3.03

307.65

4.6

2.6

567.24

532.61

mosm/kgh2o

2.48

3497

14355

(3012544) pH of Venous blood

2790

7829

4.42

307.65

4.7

4.0

7.39

7.38

6.02

2359

4285

(3027273) Bicarbonate [Moles/volume] in Venous blood

2080

3015

8.25

307.65

4.0

3.4

25.63

25.10

mmol/l

8.80

2060

2898

(3000330) Specific gravity of Urine by Test strip

2557

3740

8.57

307.65

5.2

2.7

1.02

ratio

22.84

2389

3272

(3008037) Lactate [Moles/volume] in Venous blood

1882

1440

15.51

307.65

3.7

2.8

1.46

1.56

mmol/l

2.47

1867

1387

(3035285) Chloride [Moles/volume] in Venous blood

1054

571

20.27

307.65

2.3

106.21

105.15

mmol/l

5.18

1046

564

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1343

4093

3.59

307.65

1.7

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2110

3436

7.34

307.65

5.6

3.7

42.64

49.16

20.58

2095

3375

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1484

3919

4.21

307.65

2.9

3.1

0.72

0.62

32.46

1475

3904

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1583

3150

5.69

307.65

3.5

4.9

1.41

1.68

15.24

1565

2953

(3004119) Hemoglobin [Mass/volume] in Venous blood

2251

4517

5.99

307.65

4.0

3.3

134.66

130.86

g/l

12.16

2230

4383

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10764

72597

13.68

307.65

4.5

3.4

—

(3041354) Potassium [Moles/volume] in Venous blood

1054

571

20.27

307.65

2.3

3.99

4.03

mmol/l

1.13

1046

564

(3021589) Normoblasts [#/volume] in Blood

6999

43184

2.66

307.65

12.0

10.2

0.00

e9/l

0.48

6068

35232

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5521

33306

2.30

307.65

3.4

3.2

29.28

33.08

u/l

2.70

5335

31586

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1054

547

21.17

307.65

2.3

1.20

mmol/l

1.78

1046

540

(1761482) Bacteria [#/volume] in Urine by Culture

2153

1266

20.82

307.65

5.0

3.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

2630

6395

5.07

307.65

4.2

3.5

4.40

4.65

kpa

8.07

2607

6200

(3038515) Glucose [Moles/volume] in Venous blood

1812

1116

19.18

307.65

3.7

2.9

7.17

7.62

mmol/l

3.96

1798

1076

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2829

7725

4.56

307.65

4.7

4.0

5.73

5.83

kpa

6.00

2806

7505

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2973

15368

2.27

288.39

3.5

2.7

1.22

1.10

e6/l

0.73

1904

7849

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2753

14039

2.27

273.96

3.6

2.8

3.72

3.30

e6/l

0.47

1675

6482

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

700

1689

4.35

262.55

1.8

2.3

0.78

0.86

nmol/l

2.27

578

1460

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3622

21277

2.04

245.55

2.1

1.7

1.03

1.07

mg/l

0.29

2886

15968

(3021440) Promyelocytes/Leukocytes in Blood

1704

7672

2.44

221.34

5.7

4.5

0.08

0.13

1.63

383

1812

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1568

6851

2.50

217.14

2.9

2.3

0.31

0.37

e6/l

0.49

1519

6490

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6012

43079

1.85

215.10

8.9

6.6

1.21

mmol/l

0.10

5691

37310

(3017181) Myelocytes/Leukocytes in Blood

1732

7973

2.39

213.55

5.7

4.5

0.86

0.92

0.27

411

2106

(3002179) Metamyelocytes/Leukocytes in Blood

1675

7621

2.41

211.90

5.4

4.3

0.74

0.66

0.47

341

2003

(3002030) Lymphocytes/Leukocytes in Blood

6431

47367

1.84

207.26

8.3

6.3

28.33

29.10

7.24

6219

45130

(3022096) Basophils/Leukocytes in Blood

6246

45621

1.84

206.59

8.4

6.4

0.66

0.69

5.00

5948

42895

(3018010) Neutrophils/Leukocytes in Blood

6335

46555

1.83

204.49

8.2

6.2

57.18

56.43

6.03

6168

44680

(3001604) Monocytes [#/volume] in Blood

6635

49964

1.81

192.12

8.2

6.3

0.57

0.56

e9/l

1.01

5910

43541

(3019069) Monocytes/Leukocytes in Blood

6199

45753

1.80

192.09

8.3

6.4

8.46

8.57

2.86

5931

43145

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

9927

85606

2.41

190.94

22.9

16.4

332.64

332.92

g/l

2.38

9888

85138

(3013115) Eosinophils [#/volume] in Blood

6806

51740

1.81

189.81

8.5

6.5

0.20

0.19

e9/l

0.22

6082

45798

(3006504) Eosinophils/Leukocytes in Blood

6178

45684

1.79

188.88

8.3

6.3

2.71

2.85

5.11

5925

43025

(3006315) Basophils [#/volume] in Blood

6628

50065

1.79

188.11

8.2

6.3

0.04

e9/l

0.77

5912

43594

(3019198) Lymphocytes [#/volume] in Blood

6748

51407

1.79

184.27

8.2

6.3

1.97

1.96

e9/l

0.20

6071

45857

(3021601) Nitrite [Presence] in Urine by Test strip

6812

52110

1.79

182.62

5.0

3.5

0.00

estimate

4.20

1403

10859

(3013650) Neutrophils [#/volume] in Blood by Automated count

7169

55814

1.79

179.36

11.3

9.1

4.10

4.03

e9/l

1.93

6447

48612

(3009261) Glucose [Presence] in Urine by Test strip

6874

52934

1.77

177.84

5.1

3.5

0.77

0.23

estimate

0.32

1351

10503

(3025159) Blasts/Leukocytes in Blood

1624

7830

2.26

177.28

5.9

4.7

0.07

0.21

1.20

309

1721

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

9722

83722

2.23

177.17

24.2

15.8

13.39

13.42

1.58

9689

82661

(3035350) Ketones [Presence] in Urine by Test strip

6824

52661

1.76

172.86

5.1

3.5

1.79

4.05

estimate

0.91

1445

10963

(3023368) Bacteria identified in Blood by Culture

3429

21736

1.83

172.33

5.3

3.9

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1202

5147

2.50

171.62

1.3

231.96

225.64

miu/ml

0.23

591

2534

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1403

6497

2.33

167.96

3.9

3.6

1.23

mmol/l

2.04

1344

5603

(3041096) Erythrocytes [Presence] in Urine by Automated

4329

29654

1.75

165.52

4.9

2.9

0.32

0.14

estimate

0.34

1066

8858

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

565

1627

3.60

164.32

1.1

212.36

6961.63

iu/ml

0.62

387

(3018095) Leukocytes [#/volume] in Urine

4897

34815

1.72

163.14

4.9

3.6

90.19

81.13

e6/l

0.18

3416

23528

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5306

38566

1.71

162.96

2.3

2.0

97.18

97.25

pmol/l

0.04

3165

20917

(3013826) Glucose [Moles/volume] in Serum or Plasma

6842

53600

1.71

156.42

6.1

4.6

6.70

6.49

mmol/l

12.01

6498

49783

(3037467) Urinalysis macro (dipstick) panel - Urine

8076

66498

1.77

151.65

6.2

4.2

2.51

8.69

—

(3030467) Casts [#/volume] in Urine by Automated count

3720

25035

1.73

147.19

4.0

3.0

0.31

0.38

e6/l

0.48

2840

17914

(3002582) Erythrocytes [#/volume] in Urine

4145

29019

1.68

139.86

4.1

3.1

45.72

65.60

e6/l

1.37

3220

21760

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4369

31448

1.64

129.50

4.5

3.1

44.32

69.65

ng/l

0.51

2759

18177

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6056

47526

1.60

123.27

6.9

6.0

10.34

11.12

umol/l

6.76

5824

45144

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

733

2927

2.61

119.71

1.3

1.2

3.87

4.21

0.31

497

(40760892) CBC W Ordered Manual Differential panel - Blood

3487

24115

1.65

118.64

6.2

4.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1582

8706

1.95

117.84

2.3

1.6

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

8313

70976

1.67

115.02

4.7

4.1

10.79

10.23

mm/h

3.45

7995

67075

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

10049

90733

2.05

114.48

18.1

12.1

87.60

88.43

ml/min/173m2

3.48

9471

82714

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1617

9103

1.91

112.09

2.2

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8307

71122

1.65

111.35

3.7

3.2

40.18

40.99

u/l

0.50

8038

67854

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2101

12860

1.78

111.04

2.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

880

4039

2.28

105.42

2.6

2.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5180

40121

1.54

104.78

5.1

3.4

0.51

0.22

estimate

0.27

1096

9057

(3013139) Helicobacter pylori Ag [Presence] in Stool

1303

6992

1.98

103.58

1.3

1.2

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

10494

96962

2.32

102.53

21.0

12.9

21.63

21.89

mg/l

0.37

9074

78200

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9989

90688

1.95

101.58

6.3

5.3

1.84

1.81

mu/l

1.64

9710

85712

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

627

2577

2.52

96.03

2.1

1.9

1.25

2.22

ug/l

2.28

564

2305

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2998

20905

1.59

94.14

3.5

2.9

1192.77

1117.22

ng/l

0.41

2649

17526

(3044640) Blood type and Crossmatch panel - Blood

4145

31106

1.53

93.67

2.6

2.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8187

70994

1.57

92.23

9.5

7.6

77.26

76.37

u/l

1.04

7957

67585

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1535

9115

1.79

88.01

5.0

4.4

237.68

237.03

u/l

0.06

1494

8646

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1987

12690

1.69

87.86

2.3

2.1

29.42

29.43

0.01

1954

12315

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9757

88775

1.77

86.71

4.7

3.8

1.23

1.26

mmol/l

3.50

9421

83682

(3000991) Gas panel - Venous blood

1256

7053

1.88

86.21

10.3

8.7

—

(3042936) Bacteria identified in Isolate by Culture

1941

12476

1.67

83.28

2.2

1.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

1322

7636

1.83

82.74

1.4

1.3

163.56

234.00

u/ml

2.41

1229

7117

(3019550) Sodium [Moles/volume] in Serum or Plasma

10243

94864

1.94

82.19

21.8

14.2

139.73

139.63

mmol/l

4.61

10133

92926

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

564

2373

2.45

81.95

1.6

1.5

19.59

9.94

iu/ml

0.61

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9788

89535

1.74

80.10

5.3

4.4

5.93

5.75

mmol/l

28.94

9491

83877

(3024561) Albumin [Mass/volume] in Serum or Plasma

4953

39417

1.46

79.54

5.5

4.8

36.48

36.56

g/l

0.45

4775

37108

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2112

14081

1.62

77.75

3.1

2.4

2.42

2.40

g/l

0.72

2006

13034

(3007164) IgA [Mass/volume] in Serum or Plasma

3149

23008

1.51

77.11

1.6

1.5

2.21

2.26

g/l

0.74

2046

14994

(3023103) Potassium [Moles/volume] in Serum or Plasma

10237

95094

1.90

76.87

21.9

14.3

3.93

3.94

mmol/l

2.50

10104

92954

(3024731) MCV [Entitic mean volume] in Red Blood Cells

11091

106739

5.41

76.15

29.7

19.9

90.24

90.42

4.65

11064

105882

(3035941) MCH [Entitic mass]

11091

106742

5.41

76.09

29.7

19.9

30.08

30.17

7.27

11065

105885

(3022948) Iron [Moles/volume] in Serum or Plasma

2248

15285

1.59

76.01

3.1

2.5

13.17

13.97

umol/l

5.53

2149

14330

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

11091

106750

5.40

75.91

30.4

20.3

39.78

41.20

15.78

11057

105840

(3026361) Erythrocytes [#/volume] in Blood

11091

106756

5.40

75.77

29.8

20.0

4.51

4.53

e12/l

5.11

10990

104723

(3010813) Leukocytes [#/volume] in Blood

11092

106773

5.43

75.77

29.9

20.1

6.79

6.71

e9/l

2.87

10980

104707

(3000963) Hemoglobin [Mass/volume] in Blood

11092

106782

5.42

75.57

30.1

20.1

134.80

135.91

g/l

15.07

11073

105945

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8786

78580

1.55

75.01

4.9

4.5

14.68

14.52

pmol/l

8.86

8402

73348

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5615

46071

1.44

74.84

3.1

2.7

—

estimate

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

10149

94142

1.84

74.83

5.2

4.5

4.58

4.70

mmol/l

34.91

9859

89669

(3007461) Platelets [#/volume] in Blood

11084

106703

5.09

74.36

29.8

20.0

259.53

258.59

e9/l

0.86

10991

104895

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10739

101668

2.40

74.06

13.6

10.6

26.08

26.38

u/l

0.68

10606

99295

(3048689) Calprotectin [Mass/mass] in Stool

2241

15315

1.58

73.86

2.6

103.51

119.58

ug/g

1.95

1872

12218

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

10215

95006

1.86

73.77

5.7

5.0

2.72

2.79

mmol/l

12.97

9933

90131

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

10105

93705

1.81

73.27

5.2

4.4

1.45

1.47

mmol/l

4.13

9808

88875

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3831

29396

1.46

72.39

3.0

2.6

55.75

61.73

u/l

1.35

3650

27360

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

407

1571

2.65

70.72

1.2

1.1

2.10

2.81

0.94

313

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

812

4204

2.00

70.36

2.0

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3208

23987

1.47

68.37

1.8

1.6

20.60

20.03

nmol/l

1.51

2947

20826

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

483

2070

2.39

67.24

1.2

1.1

32.12

15.75

au/ml

2.60

127

589

(3020564) Creatinine [Moles/volume] in Serum or Plasma

10716

101781

2.25

66.07

23.6

15.9

75.44

73.09

umol/l

9.95

10664

100679

(3000494) Fungus identified in Specimen by Culture

1749

11595

1.60

64.63

1.7

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3258

24664

1.45

64.27

2.6

2.3

2.80

2.68

mg/l

2.34

2867

21484

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

545

2515

2.23

63.78

2.5

2.2

10.09

10.18

g/l

0.18

509

2281

(3047007) Chlamydophila sp Ab [Presence] in Serum

410

1675

2.50

63.34

1.4

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

1406

8888

1.67

62.77

2.9

2.7

1.76

1.74

0.31

1302

7951

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3476

26742

1.43

62.46

1.4

1.50

1.69

u/ml

0.41

1066

7637

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1035

6034

1.79

61.87

1.9

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3368

25806

1.44

61.71

4.8

4.2

7.00

9.12

mg/mmol

2.59

2579

16247

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3387

25988

1.43

61.55

2.7

2.1

180.05

196.57

u/l

0.47

3247

24708

(3004775) Volume in Urine collected for unspecified duration

191

524

3.69

59.53

1.9

2.3

631.80

632.54

0.01

101

378

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1867

12803

1.55

59.04

3.2

2.5

21.88

23.49

6.09

1787

11943

(3038177) Helicobacter pylori Ab [Presence] in Serum

441

1932

2.34

58.35

1.3

1.2

—

(3036603) Volume of Urine

209

620

3.42

57.87

1.7

1.5

2170.65

2084.04

0.28

201

610

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5311

44358

1.38

57.37

2.9

2.4

75.05

74.93

nmol/l

0.12

5040

41209

(3014111) Lactate [Moles/volume] in Serum or Plasma

1167

7185

1.70

57.27

8.6

7.5

1.33

1.31

mmol/l

0.17

1150

7049

(3033658) Prothrombin time (PT) actual/Normal

3063

23339

1.43

56.87

5.1

3.9

93.76

92.83

1.29

3005

22772

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

360

1459

2.52

56.56

1.6

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

6187

53038

1.37

56.34

3.8

3.2

107.06

94.07

ug/l

4.84

6008

50318

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

755

4131

1.89

55.22

1.8

1.6

10.85

12.06

u/ml

0.44

261

1113

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

213

664

3.25

54.49

4.5

3.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

1652

11225

1.55

53.98

2.0

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

476

2243

2.17

52.80

1.4

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2006

14283

1.49

52.46

4.3

3.3

0.82

mmol/l

1.73

1905

13485

(3023520) Reticulocytes [#/volume] in Blood

1062

6547

1.69

51.60

2.7

2.6

71.29

70.21

e9/l

0.39

764

4718

(3037522) Nuclear Ab [Titer] in Serum

2102

15198

1.47

50.68

1.5

1.4

616.42

518.54

titre

1.15

402

3095

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1366

9007

1.59

50.65

2.9

2.5

32.20

42.87

u/l

1.27

1201

7647

(46235355) HIV 1 and 2 tests - Meaningful Use set

3584

28511

1.38

50.36

2.4

2.1

—

(4024509) Urine culture

730

4071

1.85

50.18

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1199

7700

1.62

49.55

3.2

2.6

10.46

10.59

g/l

0.54

1154

7116

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

128

301

4.29

49.41

3.2

3.3

0.71

1.33

3.96

128

301

(3032080) INR in Blood by Coagulation assay

4529

37522

1.35

48.52

14.7

11.6

1.19

inr

0.10

3885

31121

(3020779) Urea [Moles/volume] in Serum or Plasma

1116

7088

1.64

48.16

10.4

7.3

9.28

8.78

mmol/l

1.58

1074

6800

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

562

2928

1.97

47.48

2.5

2.2

7.28

7.26

g/l

0.07

533

2711

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

561

2924

1.97

47.33

2.5

2.2

4.24

4.26

g/l

0.22

533

2710

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

560

2921

1.97

47.14

2.5

2.2

3.69

g/l

0.00

532

2708

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

773

4524

1.76

45.13

10.3

9.6

24.35

24.17

mmol/l

0.81

755

4437

(3009445) Proteinase 3 Ab [Units/volume] in Serum

658

3684

1.84

44.56

1.8

1.6

6.50

12.27

iu/ml

1.12

117

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

821

4909

1.73

44.41

6.5

4.2

24.00

24.20

mmol/l

1.12

816

4853

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

352

1578

2.27

44.11

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

352

1578

2.27

44.11

1.5

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

550

2937

1.92

43.16

2.8

2.7

3.88

3.51

g/l

5.34

526

2795

(3036489) Thrombin time

658

3725

1.81

42.95

2.3

2.1

20.45

20.61

0.34

599

3215

(3020630) Protein [Mass/volume] in Serum or Plasma

979

6197

1.64

42.59

3.0

2.5

66.41

66.95

g/l

1.44

921

5746

(3019309) Folate [Moles/volume] in Red Blood Cells

1798

13004

1.46

42.43

1.7

941.75

1167.30

nmol/l

26.96

1459

10107

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1569

11056

1.49

42.29

8.6

5.8

1.06

1.05

mmol/l

1.29

1482

10323

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

185

618

3.03

42.18

1.2

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2372

18064

1.40

41.91

1.8

1.7

16131026.86

29752919.77

pmol/l

0.92

2052

15555

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

333

1500

2.26

41.26

1.5

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

584

3226

1.85

41.25

1.3

—

(3025941) Bacteria identified in Stool by Culture

937

5936

1.63

40.56

1.3

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

968

6204

1.61

39.95

5.2

3.8

91.54

84.24

ng/l

1.49

828

5490

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

621

3536

1.80

39.72

2.0

1.8

1.54

1.44

g/l

1.98

561

3036

(40761536) Microorganisms panel - Urine sediment

439

8156

0.52

39.64

5.4

3.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9316

87081

1.42

39.52

7.9

5.3

39.31

38.00

mmol/mol

33.98

9053

82790

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

384

1866

2.10

39.31

1.6

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

363

1740

2.12

38.52

3.2

24.52

25.54

mg/l

0.24

283

1142

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

328

1514

2.20

38.31

1.9

1.8

3034.67

2247.27

titre

0.26

(3029634) Reagin Ab [Titer] in Serum by VDRL

369

1788

2.10

38.07

2.4

2.0

3.90

12.63

titre

—

(3006270) Folate [Moles/volume] in Blood

186

665

2.83

37.57

1.1

392.35

382.96

nmol/l

0.17

615

(36304419) Bacteria [Presence] in Urine

3024

24280

1.34

37.44

3.9

2.9

0.04

209.90

estimate

0.63

(3003694) ABO and Rh group [Type] in Blood

3891

32380

1.31

37.34

1.6

—

(44813793) Dust mix specific IgE antibody measurement

211

821

2.60

36.16

1.2

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

726

4464

1.67

35.21

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1089

7400

1.52

34.55

2.4

16.39

19.73

au/ml

1.13

963

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1027

6901

1.54

34.31

1.3

44.67

50.51

au/ml

0.38

435

(21494755) Public health laboratory ask at order entry panel

872

13022

0.64

33.71

1.2

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

525

2993

1.79

33.39

2.7

2.6

178.87

178.52

0.03

491

2849

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

390

2030

1.95

33.00

1.9

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2125

16459

1.36

32.69

2.8

2.44

2.43

mmol/l

0.67

1931

14689

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

760

4831

1.61

32.25

10.9

9.7

0.61

0.65

1.93

744

4802

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

960

6461

1.53

31.75

1.1

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1003

6828

1.52

31.43

1.6

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1349

9756

1.44

31.05

2.3

2.2

371.69

379.92

nmol/l

0.96

1274

9059

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

306

1495

2.08

30.93

4.7

2.8

30312.72

1218.27

u/ml

0.46

(3003888) Timothy IgE Ab [Units/volume] in Serum

490

2800

1.78

30.92

1.1

5.09

5.84

u/ml

0.40

256

1537

(3004809) Band form neutrophils/Leukocytes in Blood

271

1264

2.17

30.89

3.3

1.35

1.63

0.63

235

1145

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1245

8884

1.45

30.78

1.3

1.2

144.86

139.12

u/ml

0.18

429

3463

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

311

1539

2.05

30.37

1.3

1.2

204.00

363.69

titre

1.17

130

(3009508) Creatinine [Moles/volume] in Urine

3579

30061

1.28

30.26

3.3

3.4

7.98

7.93

mmol/l

0.22

3368

26049

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

227

995

2.31

30.09

1.8

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

449

2535

1.80

29.50

1.3

41.22

45.13

u/ml

0.11

233

(3043410) Blood group antigens tested for on Red Blood Cells

213

3.97

29.47

2.2

1.6

—

(3019977) pH of Arterial blood

1220

8749

1.44

29.29

8.4

7.6

7.42

0.43

629

4717

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

540

3221

1.71

29.29

2.5

2.4

96.68

94.57

1.47

515

3108

(3027801) Oxygen [Partial pressure] in Arterial blood

1218

8743

1.44

29.08

8.4

7.6

12.09

13.11

kpa

9.13

1162

8416

(3028026) IgM [Mass/volume] in Serum or Plasma

891

6015

1.52

28.97

2.2

1.9

1.43

1.29

g/l

0.73

840

5604

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1217

8745

1.44

28.88

8.5

7.6

5.06

5.07

kpa

0.15

1162

8418

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

764

4991

1.57

28.81

10.8

9.4

1.30

1.34

0.48

749

4964

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

179

720

2.51

28.72

2.0

2.4

—

(3011412) CD3 cells [#/volume] in Blood

215

940

2.31

28.69

2.2

2.6

1211.30

1262.80

e6/l

0.37

175

807

(3012516) Albumin [Mass/volume] in Urine

3073

25466

1.28

28.54

3.2

3.5

48.42

52.68

mg/l

0.46

2059

16338

(3003396) Base excess in Arterial blood by calculation

1204

8664

1.44

28.32

8.4

7.6

0.71

0.77

mmol/l

0.20

955

7012

(3008401) Mugwort IgE Ab [Units/volume] in Serum

466

2693

1.76

28.29

1.1

0.85

1.18

u/ml

0.48

217

1205

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

530

3192

1.69

27.74

2.0

1.9

0.23

g/l

0.26

514

3048

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

463

2.87

27.73

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

397

2201

1.83

27.70

1.6

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

245

1151

2.15

27.47

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

173

4.18

27.18

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

249

3.59

27.16

1.7

2.1

1.62

1.79

ratio

0.47

243

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

359

1950

1.87

26.74

7.3

5.0

386.02

1715.51

iu/ml

0.76

233

(1175426) CD3 cells/Lymphocytes in Blood

184

779

2.38

26.45

2.0

2.3

74.20

73.94

0.09

177

755

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

433

2507

1.76

26.13

1.3

11.68

17.77

u/ml

—

(3016502) Oxygen saturation in Arterial blood

1074

7680

1.44

26.04

8.9

8.0

95.09

95.97

3.17

1032

7395

(42529406) Shigella sp [Presence] in Stool by Culture

465

2751

1.72

25.99

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

536

3299

1.66

25.82

2.0

1.8

1.21

1.19

g/l

0.80

520

3160

(4034850) Laboratory test

103

2843

0.36

25.80

7.0

8.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

462

2736

1.72

25.73

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

460

2731

1.71

25.38

1.2

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2439

19880

1.29

25.23

1.4

1.3

46.28

27.60

iu/ml

0.65

694

5831

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1973

15633

1.32

25.21

4.7

3.4

213.79

491.79

ng/l

2.96

1420

10447

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

411

2370

1.76

25.16

1.4

1.3

249.09

256.42

u/ml

0.22

270

1498

(3000570) Elastase.pancreatic [Mass/mass] in Stool

450

2666

1.72

25.03

1.5

1.4

298.61

284.52

ug/g

0.72

259

1456

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

270

1363

2.01

25.01

2.0

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

431

2530

1.73

24.78

1.4

1.2

33.56

50.87

u/ml

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

354

1967

1.83

24.55

2.9

2.2

0.00

g/l

-0.00

338

1861

(3017143) Hepatitis C virus Ab [Presence] in Serum

1938

15374

1.32

24.47

1.9

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

266

1352

1.99

24.19

1.3

31.70

56.00

u/ml

1.03

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

379

2161

1.78

24.12

3.2

3.5

0.33

0.34

iu/ml

0.11

193

1192

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

348

1939

1.82

23.92

1.1

22.48

0.37

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

329

1802

1.85

23.90

1.2

3.99

3.00

u/ml

0.28

117

687

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

403

2351

1.74

23.70

1.3

3.82

3.63

mmol/l

2.76

390

2216

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

417

2458

1.72

23.63

1.3

2.54

3.87

u/ml

0.52

156

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

395

2295

1.75

23.56

1.6

1.4

13.23

23.97

u/ml

1.58

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

173

751

2.32

23.55

2.0

2.3

14.08

14.18

0.05

173

734

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

373

2134

1.77

23.47

1.6

1.4

148.73

146.00

au/ml

0.16

113

573

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

524

3291

1.62

23.29

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

844

5892

1.47

23.15

3.3

2.2

5.53

7.19

ug/l

2.40

728

5223

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

515

3231

1.62

22.99

1.1

1.63

2.24

u/ml

0.92

263

1714

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

370

2128

1.76

22.87

2.0

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

317

1742

1.84

22.80

1.2

3.67

4.05

u/ml

0.19

144

812

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

518

3266

1.61

22.66

1.3

27.06

40.26

u/ml

0.76

202

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

309

1690

1.85

22.57

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1432

10995

1.35

22.51

3.2

2.7

7.88

7.45

umol/l

0.32

1240

9530

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

394

2320

1.72

22.42

1.3

1.5

9.87

24.00

e6/l

2.40

291

1716

(3000012) Reticulocyte production index

204

976

2.11

21.91

1.8

2.1

0.92

0.90

0.10

154

622

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

754

5206

1.48

21.85

2.1

1.9

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

994

7230

1.41

21.79

9.3

8.4

121.80

122.25

g/l

0.30

973

7053

(3014148) Varicella zoster virus Ab [Titer] in Serum

328

1854

1.79

21.53

1.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

365

2129

1.74

21.50

6.8

3.7

8.45

8.65

kpa

1.32

358

2074

(3044889) 12 lead EKG panel

6843

63098

1.22

21.48

3.6

3.5

0.60

3851.17

—

107

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

395

2358

1.70

21.39

1.5

296.75

2538.01

e6/l

0.78

318

1850

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

388

2305

1.71

21.39

1.6

1.4

—

(3010503) CD19 cells [#/volume] in Blood

131

526

2.51

21.22

2.3

2.8

392.99

211.59

e6/l

0.28

123

516

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

480

3022

1.61

21.14

1.4

1.3

10.55

9.55

u/ml

0.09

437

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

480

3029

1.61

20.94

1.4

1.3

17.96

5.09

u/ml

0.63

276

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

432

2658

1.65

20.86

1.3

1.4

440.87

492.66

mg/l

1.79

424

2538

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

127

507

2.52

20.84

2.1

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

332

2.91

20.81

2.2

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

332

2.91

20.81

2.2

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

361

2119

1.73

20.80

2.9

2.1

0.01

0.00

g/l

0.46

338

1864

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

343

1987

1.75

20.71

3.3

3.1

1.82

2.61

ratio

1.23

218

1121

(3021901) Oxygen saturation in Capillary blood

281

1534

1.85

20.68

3.4

2.7

90.50

90.92

0.52

273

1492

(44790047) Parainfluenza type 1 nucleic acid detection

212

1053

2.03

20.62

1.9

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

212

1053

2.03

20.62

1.9

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

372

2210

1.71

20.52

2.9

2.1

0.09

0.02

g/l

0.46

350

2004

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

187

888

2.12

20.51

1.8

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

293

1625

1.82

20.50

1.9

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

446

2779

1.63

20.49

2.2

193.76

574.33

ug/l

4.31

418

2584

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

270

4779

0.55

20.36

1.3

1.6

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

6.91

20.33

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

234

1210

1.95

20.32

1.1

92.77

96.43

1.22

213

1144

(3016228) CD19 cells/cells in Blood

342

2.85

20.31

1.8

2.2

8.91

8.36

0.14

336

(44790049) Parainfluenza type 3 nucleic acid detection

211

1053

2.02

20.27

1.9

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

211

1053

2.02

20.27

1.9

1.4

—

(40758558) Short blood count panel - Blood

3296

28394

1.23

20.26

7.1

6.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2783

23564

1.24

20.10

4.1

3.5

0.17

0.01

188

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

641

4355

1.50

20.10

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

292

1628

1.81

20.09

1.5

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

262

1420

1.87

19.74

2.6

2.5

37.91

29.19

iu/ml

0.33

104

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1024

7619

1.38

19.55

2.5

2.4

4962.54

6580.93

u/l

1.01

365

3041

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

610

4132

1.50

19.41

2.0

39.12

39.85

u/l

0.42

562

3772

(3004451) EKG impression Narrative

365

2.73

19.09

1.2

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

535

2.41

19.07

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

126

523

2.43

19.06

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

168

795

2.13

18.64

1.9

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

102

4.43

18.40

3.3

6.5

7.94

8.44

mmol/l

0.37

102

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2197

18295

1.25

18.17

1.4

1.3

8.79

9.44

u/ml

0.20

1027

7601

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2766

23626

1.23

18.04

2.6

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3519

30784

1.21

18.04

3.4

3.3

2.35

mmol/l

0.62

3243

28308

(44806420) Estimation of glomerular filtration rate

235

1268

1.87

18.00

2.7

2.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1020

7694

1.36

17.81

4.0

4.2

16.39

26.41

ug/l

0.48

811

5996

(21494814) CD8 cells/Lymphocytes in Specimen

354

2.67

17.44

1.8

2.2

32.17

30.13

0.64

354

(3001019) Free T4 and TSH panel - Serum or Plasma

470

6991

0.66

17.23

1.6

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

193

990

1.97

17.22

1.8

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

150

705

2.14

16.98

3.3

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

162

785

2.08

16.94

1.3

1.2

85.43

82.17

0.39

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

431

2791

1.57

16.89

2.7

2.2

2.96

2.85

g/l

1.65

402

2576

(3026493) Urate [Moles/volume] in Serum or Plasma

2747

23584

1.22

16.83

3.1

2.4

329.90

328.33

umol/l

0.36

2502

21280

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

753

5455

1.41

16.81

1.1

20.53

2.13

u/ml

0.61

(3034860) Kappa light chains.free [Mass/volume] in Serum

359

2237

1.62

16.55

3.3

3.2

50.11

72.89

mg/l

0.45

336

1894

(3042111) Morphology [Interpretation] in Bone marrow Narrative

214

1156

1.87

16.37

1.7

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

289

1707

1.71

16.36

2.1

2.4

91.47

108.42

ug/min

0.24

135

1072

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

439

2877

1.55

16.32

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2382

20212

1.23

16.30

5.2

4.9

2.60

2.66

ug/l

0.04

2235

18409

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

398

2553

1.58

16.26

2.8

2.2

0.76

0.68

g/l

0.20

366

2224

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

482

2.36

16.16

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

357

2235

1.62

16.15

3.3

3.2

40.95

43.43

mg/l

0.14

334

1892

(3037121) Protein [Mass/volume] in Urine

449

2975

1.53

15.88

3.3

305.62

393.00

mg/l

0.79

192

1373

(3012494) Peanut IgE Ab [Units/volume] in Serum

378

2.53

15.81

1.1

0.98

13.27

u/ml

0.88

234

(3028192) IgG subclass 2 [Mass/volume] in Serum

204

1107

1.86

15.42

1.3

3.00

3.06

g/l

0.23

182

777

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

431

2851

1.53

15.37

5.8

4.0

1.34

1.38

mg/l

0.42

397

2653

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

417

2740

1.54

15.34

3.0

3.6

2484.71

2159.69

u/ml

0.05

348

2371

(3004716) Salmonella sp identified in Stool by Organism specific culture

824

6159

1.36

15.21

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

203

1106

1.85

15.16

1.3

0.46

0.39

g/l

0.87

179

774

(3027135) IgG subclass 1 [Mass/volume] in Serum

203

1106

1.85

15.16

1.3

6.47

6.69

g/l

0.49

180

776

(3024891) Influenza virus A+B Ag [Presence] in Specimen

458

3094

1.50

14.80

1.2

1.1

—

(4268621) Lupus anticoagulant assay

227

1292

1.77

14.69

2.2

2.3

—

(4062490) Immunoglobulin typing, IgG

198

1087

1.84

14.45

1.4

1.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

395

2.42

14.43

49.7

38.5

7.24

7.21

ug/l

0.04

360

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

136

657

2.08

14.41

2.4

2.9

0.72

0.75

e9/l

0.24

122

641

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

114

515

2.23

14.32

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

406

2695

1.53

14.27

1.4

1.3

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

151

761

2.00

14.26

1.1

1.3

0.58

0.65

ratio

1.19

104

445

(3050129) First trimester maternal screen panel - Serum or Plasma

871

6635

1.34

14.19

1.5

—

(3018418) pH of Serum or Plasma

2947

25809

1.19

14.16

5.1

4.0

7.39

7.40

2.95

2070

18172

(3024928) Oxygen saturation in Venous blood

325

2056

1.60

14.13

4.6

3.4

62.57

62.32

0.07

315

1995

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

271

1639

1.67

14.10

1.1

119.49

116.22

0.90

241

1500

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2728

23734

1.20

14.10

1.9

1.8

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

183

989

1.86

14.05

1.2

44.64

40.10

mg/l

0.17

170

826

(3023511) Choriogonadotropin [Units/volume] in Urine

546

3863

1.43

13.93

1.5

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

147

3.34

13.63

2.4

2.5

—

(3010421) pH of Blood

385

2555

1.52

13.57

3.3

3.5

7.40

7.41

7.90

385

2524

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

141

711

2.00

13.33

2.4

2.7

501.91

520.55

e6/l

0.15

564

(3019150) Specific gravity of Urine by Refractometry

2030

23704

0.82

13.31

4.0

3.6

1.02

1.22

kg/l

1.08

1392

15215

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

509

3593

1.44

13.16

1.5

1.6

0.19

5.92

iu/ml

0.56

106

633

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

197

2.95

13.14

1.5

1.2

13.95

12.82

pmol/l

0.13

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

918

7127

1.31

13.08

2.9

3.5

4.46

4.57

pmol/l

3.41

827

6474

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

176

962

1.84

13.07

1.1

275.62

239.81

mg/l

0.39

165

852

(3006184) Hemoglobin [Mass/volume] in Capillary blood

300

1898

1.60

13.07

2.4

2.0

130.99

131.56

g/l

0.14

221

1486

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

205

1174

1.76

13.04

1.1

—

20.72

—

(3000060) B lymphocytes [#/volume] in Blood

374

2.36

12.79

2.1

2.4

0.21

0.23

e9/l

0.18

172

(3028707) Methadone [Presence] in Urine by Screen method

437

3018

1.47

12.69

3.2

2.8

—

(3020874) Milk IgE Ab [Units/volume] in Serum

171

936

1.84

12.66

1.1

1.66

2.35

u/ml

0.32

318

(3009871) Measles virus Ab [Titer] in Serum

445

2.24

12.64

1.9

1.7

1796.00

2881.13

titre

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

4.61

12.56

5.9

3.7

2.15

2.56

mg/l

0.31

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

354

2352

1.52

12.44

2.7

2.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

161

3.11

12.43

3.9

2.8

73.56

204.07

ug/l

0.31

161

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

663

1.99

12.29

1.9

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

663

1.99

12.29

1.9

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

663

1.99

12.29

1.9

1.5

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

382

2.31

12.21

1.0

1.1

5.89

4.08

iu/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

160

873

1.84

11.99

1.1

9.56

7.63

iu/ml

0.39

250

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.76

11.96

10.1

10.6

5.88

5.65

mmol/l

0.18

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

288

2.51

11.96

3.3

2.7

0.61

mmol/l

0.10

288

(3015235) Bicarbonate [Moles/volume] in Capillary blood

390

2668

1.48

11.91

3.7

2.7

25.31

24.49

mmol/l

4.13

382

2618

(3024980) IgG subclass 4 [Mass/volume] in Serum

282

1801

1.58

11.85

1.7

1.6

0.67

0.75

g/l

0.73

246

1402

(3018405) Lactate [Moles/volume] in Arterial blood

353

2369

1.51

11.85

3.3

3.7

1.42

1.38

mmol/l

0.35

327

2332

(3023410) Appearance of Cerebral spinal fluid

188

1082

1.75

11.81

1.4

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

380

2591

1.48

11.80

2.0

2.1

11.43

11.00

mg/l

0.55

364

2449

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

240

1476

1.64

11.78

1.2

1.67

1.05

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

165

915

1.82

11.75

1.1

1.44

6.04

u/ml

0.58

239

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

159

876

1.83

11.57

1.5

1.8

148.89

1217.17

pmol/l

0.71

105

(3023420) DNA double strand Ab [Units/volume] in Serum

607

4516

1.36

11.55

2.1

1.9

13.35

6.90

iu/ml

0.43

173

1094

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

337

2253

1.51

11.53

1.3

1.4

25.06

22.67

u/l

0.67

278

1861

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

176

1001

1.77

11.53

6.3

6.4

12.07

11.19

mg/l

1.77

170

937

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

425

0.12

11.49

1.4

1.3

48.20

70.27

ug/l

—

425

(3017732) Neutrophils [#/volume] in Blood

1488

12436

1.23

11.40

2.9

3.0

4.27

4.42

e9/l

0.76

1307

11032

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

164

922

1.79

11.18

1.1

19.48

17.44

u/ml

0.36

401

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.70

11.09

2.4

1.3

—

(3020891) Body temperature

497

3604

1.40

11.08

4.0

4.1

36.93

36.92

°c

0.06

491

3569

(3011288) Drugs identified in Urine by Screen method Nominal

680

5183

1.33

11.04

3.2

2.8

—

(4195642) Thrombophilia screening test

258

1644

1.58

10.98

1.2

—

(3035880) pH of Pleural fluid

301

2.40

10.92

1.4

1.3

7.41

7.39

0.37

198

(3003434) Protein [Mass/volume] in Pleural fluid

150

828

1.82

10.88

1.7

1.5

34.25

33.53

g/l

0.29

134

749

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

386

2.21

10.66

1.1

20.91

441.70

ng/l

1.24

100

(3037692) Legionella sp identified in Specimen by Organism specific culture

228

2.60

10.57

1.8

1.2

—

(4198724) Urine methamphetamine measurement

127

673

1.90

10.49

3.5

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

746

5815

1.30

10.32

1.1

44.33

206.82

titre

4.97

173

(3015171) Extractable nuclear Ab [Units/volume] in Serum

572

4301

1.35

10.19

1.3

0.70

1.05

u/ml

0.41

337

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

150

846

1.78

10.17

1.6

1.3

1.61

2.49

u/ml

0.69

468

(36660697) Celiac disease serology panel - Serum

1125

9241

1.24

10.10

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

134

732

1.84

10.09

2.6

2.8

201.06

223.71

e6/l

0.85

102

602

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

922

1.75

10.08

1.1

—

(3006245) CD3-CD19+ cells/cells in Blood

477

2.04

9.95

2.4

2.6

8.54

9.05

0.23

453

(3017569) Oxygen content in Arterial blood

334

2.25

9.89

1.9

2.2

15.96

16.30

0.38

334

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

105

3.34

9.82

1.3

1.2

2.08

1.67

iu/ml

0.66

(3013005) Retinol [Moles/volume] in Serum or Plasma

105

534

1.98

9.82

2.1

2.0

1.97

1.85

umol/l

0.91

487

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

110

570

1.94

9.75

1.6

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

132

727

1.83

9.70

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

203

2.62

9.70

1.2

1.4

0.32

0.23

mmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

257

2.42

9.63

1.9

1.4

—

(3042733) HLA Ab [Presence] in Serum

270

2.38

9.57

5.8

4.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

268

1779

1.52

9.56

3.0

31.80

35.12

umol/l

1.54

244

1639

(3039443) Prostate specific Ag panel - Serum or Plasma

209

1312

1.60

9.53

1.6

—

(3023419) Bacteria identified in Sputum by Culture

155

900

1.73

9.53

3.6

2.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

138

775

1.79

9.52

1.4

12.16

11.34

umol/l

0.67

133

731

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

413

2.09

9.42

2.2

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

591

4521

1.32

9.39

6.5

3.5

1.96

1.43

mmol/l

2.81

454

3219

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

238

1556

1.54

9.13

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

412

2.07

9.10

2.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

412

2.07

9.10

2.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

412

2.07

9.10

2.2

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

442

3261

1.37

8.94

2.7

1.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

195

2.57

8.86

2.0

1.7

46.28

43.25

u/l

0.03

180

(1002224) Polysomnography panel

712

5630

1.28

8.85

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

165

998

1.66

8.77

1.2

—

(3001729) Color of Synovial fluid

4.01

8.77

1.2

1.5

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

147

862

1.71

8.77

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

675

0.25

8.76

4.5

2.8

70.60

57.50

mg/l

0.08

503

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

2.13

2.03

mg/l

0.05

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

2.79

1.74

mg/l

0.39

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

3.24

3.15

mg/l

0.03

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

2.49

1.79

mg/l

0.30

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

0.83

1.40

mg/l

0.45

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

4.95

4.03

mg/l

0.21

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

2.61

2.70

mg/l

0.02

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

3.34

8.73

1.6

1.5

0.85

1.09

mg/l

0.21

(3018333) Ribosomal P Ab [Presence] in Serum

143

834

1.72

8.70

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

140

816

1.72

8.54

1.2

1.3

1.84

1.96

mmol/l

1.31

133

760

(3037756) Immunofixation for Serum or Plasma

204

1313

1.56

8.42

1.8

1.7

—

(3024471) HLA-A [Type]

257

2.30

8.26

1.0

—

(21494434) Karyotype in Bone marrow

113

625

1.82

8.26

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

3.20

8.19

1.6

0.69

2.20

mg/l

2.26

(40768446) Kidney Pathology biopsy report

349

2.10

8.15

2.1

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

364

4947

0.73

8.11

1.1

0.60

0.62

ratio

0.32

512

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

144

860

1.68

8.07

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

175

1099

1.60

8.05

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

148

895

1.66

7.92

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

148

895

1.66

7.92

1.2

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

3.34

7.91

1.9

1.5

7.30

7.02

—

(3045424) Erythrocytes [Presence] in Urine

337

4615

0.72

7.89

2.1

2.0

0.00

0.17

estimate

0.61

1655

(3016650) Hepatitis A virus Ab [Presence] in Serum

269

1862

1.46

7.88

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

156

959

1.64

7.83

1.3

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

141

846

1.68

7.78

1.3

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

642

0.28

7.76

1.4

4.98

5.43

mmol/l

1.56

609

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

390

2.01

7.75

1.1

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

789

9633

0.81

7.73

6.8

5.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

404

1.99

7.73

1.5

1.8

160.72

152.65

0.42

379

(3006576) Bicarbonate [Moles/volume] in Blood

221

2.36

7.73

4.7

6.2

24.97

24.77

mmol/l

0.14

206

(40759836) Histone Ab [Presence] in Serum by Immunoblot

148

901

1.65

7.73

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

4.17

7.72

2.9

1.4

40.80

48.96

umol/l

0.72

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

400

2983

1.35

7.61

2.5

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

114

651

1.76

7.53

1.6

1.5

128111.62

57446.36

e6/l

0.51

362

(3022670) pH of Venous cord blood

4.09

7.52

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

450

1.92

7.51

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.38

7.50

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

332

2410

1.39

7.48

3.0

2.9

2.66

2.15

index

0.53

180

1268

(3026389) Candida sp identified in Specimen by Organism specific culture

231

1569

1.48

7.48

1.3

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

170

2.54

7.47

3.0

4.4

42.28

68.02

u/l

1.09

164

(3003181) Sodium [Moles/volume] in Urine

205

1359

1.52

7.46

1.6

1.4

62.33

64.17

mmol/l

0.24

162

1088

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

295

2.14

7.46

2.2

1.9

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

100

551

1.82

7.45

1.2

1.1

—

(3024932) HLA-DR beta [Type]

251

2.24

7.38

1.2

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

439

1.92

7.37

2.2

2.4

28.15

27.56

0.15

422

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

149

923

1.62

7.29

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

178

1151

1.56

7.27

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

172

1104

1.57

7.26

1.7

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

319

2.08

7.21

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

181

1177

1.55

7.21

1.7

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

394

1.96

7.20

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

150

934

1.61

7.19

1.7

1.9

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

116

2.85

7.19

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

263

1848

1.43

7.15

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

242

2.24

7.13

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

242

2.24

7.13

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

124

738

1.69

7.09

1.6

1.5

5561.64

3809.50

e6/l

0.20

518

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

178

1158

1.55

7.09

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

1095

1.56

7.07

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

171

1103

1.56

7.07

1.7

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

329

2.04

7.03

1.2

26.56

15.12

—

(40768797) Stomach Pathology biopsy report

1455

12657

1.17

7.03

1.3

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

394

5168

0.75

6.95

1.1

1.50

1.53

g/l

1.74

394

5163

(3051611) Lipemic interference index of Serum or Plasma

127

766

1.67

6.92

2.9

3.2

16.56

13.86

index

1.29

479

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

239

2.22

6.91

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

117

691

1.70

6.90

1.6

1.5

38.14

32.67

0.83

416

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

292

2.09

6.86

2.3

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

292

2.09

6.86

2.3

1.9

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

247

2.19

6.81

1.1

—

(3016879) Cocaine [Presence] in Urine

821

6802

1.22

6.80

2.4

2.1

—

(3045414) Leukocytes [Presence] in Urine

1046

8872

1.20

6.79

1.9

2.0

0.01

0.03

estimate

1.87

355

2002

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

126

2.70

6.74

2.0

1.8

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

167

2.46

6.73

1.7

1.5

1.55

2.89

0.98

142

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

242

2.20

6.72

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

309

2262

1.38

6.66

1.8

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

506

1.80

6.63

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

1346

1.49

6.63

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.71

6.62

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

159

1026

1.56

6.60

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

351

1.97

6.60

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

351

1.97

6.60

1.5

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2302

20782

1.14

6.59

2.9

2.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

450

1.85

6.56

1.3

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.25

6.54

1.0

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

111

657

1.70

6.52

2.6

2.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

552

4398

1.27

6.52

11.7

9.6

15.89

16.18

1.64

547

4226

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

134

833

1.62

6.51

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

374

1.93

6.49

1.7

2.2

8.16

7.88

mmol/l

0.20

374

(3009343) pH of Capillary blood

638

5181

1.25

6.40

6.7

3.5

7.42

7.41

1.23

573

4257

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

410

5286

0.77

6.39

1.2

1.1

0.88

g/l

0.11

410

5276

(3036782) Glucose [Moles/volume] in Pleural fluid

109

646

1.69

6.38

1.5

1.3

6.47

6.15

mmol/l

0.55

101

604

(3045788) Cell count panel - Pleural fluid

104

609

1.71

6.36

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

491

1.80

6.36

1.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1391

12152

1.17

6.35

2.7

3.0

0.77

0.74

ug/l

0.38

860

7226

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

477

1.81

6.34

1.6

1.5

12.50

12.35

u/l

0.08

461

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

653

5323

1.24

6.33

6.7

3.5

5.21

5.11

kpa

2.20

621

5110

(3008898) HLA-B27 [Presence]

581

4675

1.26

6.32

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

230

2.18

6.25

1.1

—

(3000850) Epithelial cells [#/volume] in Urine

2207

19943

1.13

6.19

3.2

2.6

6.20

6.53

e6/l

0.48

2010

18047

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

481

1.79

6.18

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2118

19100

1.13

6.13

2.7

2.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

106

631

1.69

6.12

2.2

2.5

99.53

98.30

0.13

582

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.96

6.09

1.2

0.57

0.65

iu/ml

0.11

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

476

1.79

6.09

1.4

1.3

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

3.59

6.02

1.2

1.5

1.09

0.66

0.19

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

507

1.76

6.02

1.3

1.2

30.70

21.03

u/l

0.75

425

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

559

1.72

6.02

1.6

1.8

146.24

135.81

0.71

530

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

247

2.11

6.01

1.4

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

5.78

5.82

1.1

1.2

62.63

70.58

0.59

(3019832) Treponema pallidum Ab [Presence] in Serum

2043

18447

1.13

5.77

1.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

100

598

1.68

5.71

1.1

1.15

6.38

nmol/l

2.62

113

(40767503) Oxygen content in Capillary blood by calculation

226

1616

1.41

5.67

3.0

2.3

16.73

16.84

0.22

219

1580

(40768806) Pleura Pathology biopsy report

106

645

1.65

5.67

1.7

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

153

1015

1.51

5.66

2.5

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

354

2716

1.31

5.65

1.1

1.48

1.88

u/ml

0.49

213

1388

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

563

1.69

5.62

1.5

1.3

367.90

375.82

u/l

0.05

534

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

253

1848

1.38

5.60

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

140

918

1.53

5.48

2.4

2.5

0.90

1.44

g/24h

2.92

100

539

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.60

5.47

1.8

2.0

214.57

273.17

ug/l

0.68

(3045142) Bone marrow Pathology biopsy report

128

824

1.56

5.45

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

399

1.81

5.39

30.8

25.4

125.46

120.02

ug/l

0.21

325

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1505

13387

1.14

5.33

2.8

2.2

—

(40768443) Skin Pathology biopsy report

518

4199

1.24

5.33

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

878

10234

0.85

5.28

3.7

4.2

33.09

32.14

1.89

660

7226

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

528

1.69

5.27

1.3

1.2

114.88

83.37

u/l

1.56

454

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

108

674

1.61

5.26

1.1

1.10

1.06

u/l

0.23

246

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1263

11111

1.15

5.24

2.6

2.1

—

(3012441) Differential panel - Pleural fluid

103

637

1.62

5.20

1.7

1.5

—

(3020650) Glucose [Presence] in Urine

404

0.27

5.14

1.2

1.5

0.00

0.04

estimate

1.60

404

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

124

804

1.55

5.14

1.1

1.2

226.25

224.21

titre

0.01

140

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.00

5.09

3.0

3.3

—

(3027008) Opiates [Presence] in Urine

861

7369

1.18

5.08

2.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

857

7332

1.18

5.08

2.4

2.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

237

2.03

5.07

1.2

1.1

102.00

84.10

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.66

5.05

7.2

5.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

265

1987

1.34

5.01

1.6

12323.99

11766.48

e6/l

0.07

180

1406

(3028300) Cannabinoids [Presence] in Urine

862

7389

1.18

5.00

2.4

2.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.69

4.99

1.0

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

239

2.01

4.97

1.1

96.13

69.12

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

388

1.78

4.95

1.2

104.07

112.11

0.98

349

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.66

4.91

5.6

3.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

2.07

4.91

1.0

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

207

2.08

4.87

1.7

1.4

69.30

64.58

0.48

170

(3005011) Chlamydia sp Ab [Titer] in Serum

155

2.26

4.87

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

147

2122

0.69

4.83

1.6

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

151

1035

1.47

4.83

3.4

3.2

0.84

0.83

nmol/l

0.06

121

820

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

144

2.30

4.75

1.8

2.5

1.08

1.37

mmol/l

0.35

106

(3022621) pH of Urine by Test strip

905

7827

1.17

4.72

2.4

6.09

6.14

0.76

539

4982

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

601

1.60

4.66

1.6

1.9

1.33

1.69

u/field

0.64

329

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.65

4.47

1.1

1.7

188.69

27.32

ng/l

0.57

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.41

4.46

5.7

3.4

96833.33

106550.00

u/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

261

1997

1.31

4.35

3.9

4.0

3.92

3.87

mmol/l

0.81

247

1981

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

527

1.62

4.32

1.5

1.4

24.14

21.87

u/ml

0.13

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

391

3150

1.25

4.32

1.6

2.2

3.69

7.49

iu/l

0.77

120

1426

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

625

5280

1.19

4.32

1.4

1.5

1.14

1.16

ratio

0.16

368

3172

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.34

4.31

1.7

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

368

1.74

4.31

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

665

5651

1.19

4.31

3.0

29.28

48.64

u/ml

4.01

643

5473

(3020393) Adenovirus Ag [Presence] in Stool

113

2.39

4.29

1.6

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

626

5299

1.19

4.24

1.4

1.5

1.00

0.94

ratio

1.94

369

3191

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

626

5299

1.19

4.24

1.4

1.5

1.18

1.19

ratio

0.09

370

3213

(3031040) Bacteria [#/volume] in Urine by Automated count

6567

63455

1.08

4.23

5.5

4.2

3004.14

1770.36

e6/l

0.59

749

(3003740) Influenza virus B Ag [Presence] in Specimen

328

2600

1.27

4.18

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

838

7281

1.16

4.14

2.3

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

328

2603

1.27

4.14

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

536

1.59

4.06

2.0

2.9

45.69

43.33

0.42

290

(40758047) Lysozyme [Mass/volume] in Pleural fluid

2.86

4.05

1.4

1.2

9.21

10.00

mg/l

0.15

(37208534) Antinuclear antibody arbitrary concentration in serum

353

1.73

4.04

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

163

1175

1.39

4.03

1.2

1.3

0.18

0.19

nmol/l

0.28

133

901

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.43

3.96

2.4

2.1

—

(4146454) Self-monitoring of blood glucose

771

0.54

3.92

2.6

2.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

198

1.97

3.90

1.1

1.2

36.48

39.25

g/l

0.52

106

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.91

3.89

1.0

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

183

1354

1.36

3.87

1.2

1.3

7.84

1.88

nmol/l

0.45

178

1309

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

127

883

1.44

3.86

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

610

5199

1.18

3.85

1.4

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.77

3.84

1.0

1.1

—

(1616796) Gas panel - Central venous blood

235

1808

1.31

3.81

4.4

3.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

683

5886

1.17

3.78

1.6

1.7

303.44

307.72

mu/l

0.11

623

5309

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

103

691

1.50

3.76

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

370

1.68

3.71

1.1

92.47

91.33

0.09

166

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

478

1.59

3.71

2.4

2.0

27.59

28.17

umol/l

0.20

446

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

349

1.69

3.65

1.0

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

583

1.53

3.65

1.5

6.38

5.92

u/l

0.22

508

(3022493) Free Hemoglobin [Mass/volume] in Plasma

372

1.67

3.64

1.9

4.5

76.32

1110.36

mg/l

0.77

265

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

208

1586

1.32

3.62

1.2

1.4

7.49

6.88

mmol/l

1.10

1461

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.47

3.62

1.4

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

118

822

1.44

3.58

3.4

3.2

53.25

56.23

0.75

712

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

382

1.65

3.57

1.1

91.42

92.93

0.15

169

(3022313) Gas panel - Capillary blood

440

3669

1.21

3.56

7.5

3.7

—

(3028433) Virus identified in Specimen by Culture

300

1.74

3.53

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

124

2.18

3.53

1.2

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

216

1663

1.30

3.52

1.6

2.0

5.62

5.19

mmol/24h

0.44

200

1498

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3734

39251

0.93

3.50

1.8

1.34

1.36

mmol/l

0.95

3511

33964

(3000093) Morphology [Interpretation] in Blood Narrative

113

786

1.44

3.47

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

124

878

1.42

3.46

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

132

2.12

3.44

1.1

1.0

3.63

3.38

kpa

0.13

114

(3034891) Synovial lining cells/cells in Synovial fluid

371

1.65

3.43

1.7

1.5

13.57

2.89

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

166

1.99

3.42

1.1

20.96

19.78

mmol/l

1.11

150

(3019420) Tryptase [Mass/volume] in Serum or Plasma

100

682

1.47

3.41

1.5

5.78

7.17

ug/l

1.31

613

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

935

8311

1.14

3.39

2.5

2.4

0.22

g/l

1.34

863

7788

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

2.66

3.39

1.5

2.5

134.25

173.56

ug/g

0.84

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

174

1309

1.33

3.36

1.2

1.4

318.00

473.81

pmol/l

1.15

158

1148

(3047189) Immunofixation for 24 hour Urine

298

1.71

3.33

2.9

1.7

—

(3011985) Renin [Units/volume] in Plasma

185

1406

1.32

3.33

1.5

1.6

53.93

71.63

mu/l

0.63

172

1281

(3007566) Smooth muscle Ab [Titer] in Serum

365

3015

1.22

3.29

1.3

149.00

119.11

titre

0.27

304

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

183

1393

1.32

3.27

1.2

1.3

0.22

0.21

nmol/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

455

1.56

3.25

1.3

51.67

54.29

titre

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.74

3.23

1.1

344.11

277.21

u/ml

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

163

1.97

3.22

1.1

0.02

0.03

u/ml

0.26

102

(4211845) Urine protein measurement

464

0.47

3.22

3.8

2.8

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

123

2.12

3.19

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

348

1.64

3.18

1.0

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

137

2.05

3.15

1.1

1.0

7.13

7.45

kpa

0.38

120

(3006598) pH of Arterial cord blood

137

2.05

3.15

1.1

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

137

2.05

3.15

1.1

1.0

-1.47

-2.55

mmol/l

—

(3016038) Potassium [Moles/volume] in Urine

515

1.52

3.14

1.5

1.2

33.82

34.19

mmol/l

0.04

459

(3002079) Sodium [Moles/time] in 24 hour Urine

475

1.54

3.14

1.2

1.3

164.97

160.22

mmol/24h

0.19

475

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

151

1.99

3.13

2.0

1.7

130.00

8303.33

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

111

2.16

3.11

1.0

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

721

1.43

3.10

1.5

1.4

161555.77

105569.37

e6/l

0.36

493

(3008757) Leukocyte morphology finding [Identifier] in Blood

109

771

1.42

3.10

4.1

3.6

—

(3008295) Osmolality of Serum or Plasma

130

949

1.37

3.08

1.5

282.37

280.25

mosm/kgh2o

0.56

101

735

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

133

976

1.37

3.05

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

263

2118

1.25

3.04

1.5

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

180

1386

1.30

2.99

1.3

35.52

29.28

u/l

0.24

161

1199

(3024263) Appearance of Synovial fluid

409

1.57

2.99

1.6

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

679

1.43

2.94

1.8

1.5

22.89

22.88

umol/l

0.00

626

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

142

1.97

2.89

1.5

1.1

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

632

7196

0.87

2.89

2.1

2.5

78.05

73.21

ml/min/173m2

1.42

330

2948

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

429

1.54

2.88

1.5

1.4

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

526

1.49

2.87

1.3

69.10

71.28

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

176

1361

1.30

2.85

5.8

5.6

356.19

368.08

umol/l

0.54

154

1186

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

137

1.97

2.79

1.5

1.1

—

(3006462) Nitrate [Presence] in Urine

424

0.49

2.76

3.9

2.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

173

1.85

2.75

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

389

4571

0.85

2.71

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

485

1.49

2.69

3.0

2.5

107.93

179.19

umol/l

2.04

242

(3005082) Progesterone [Moles/volume] in Serum or Plasma

142

1077

1.32

2.67

1.4

31.38

36.21

nmol/l

0.95

129

992

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.28

2.67

1.1

—

3.50

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

140

1.93

2.64

1.3

1.8

5.70

380876.39

nmol/l

1.28

115

(3024316) Viscosity of Plasma

3.14

2.64

4.1

1.4

1.76

1.68

mpas

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

264

3203

0.82

2.62

1.0

1.1

2.33

5.71

eliau/ml

3.26

475

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

622

5484

1.14

2.61

3.2

2.7

189.62

163.74

ng/l

0.83

554

4930

(3004446) Plasmodium sp identified in Blood by Light microscopy

113

2.04

2.60

2.3

2.8

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

384

1.54

2.59

1.2

1.1

79.22

59.82

u/ml

0.99

376

(3006571) Granulocytes/Leukocytes in Synovial fluid

121

902

1.35

2.57

1.7

1.6

57.39

54.60

0.32

568

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

183

1445

1.27

2.56

1.3

1.2

27.67

17.58

u/ml

0.28

(3027231) Wheat IgE Ab [Units/volume] in Serum

276

1.63

2.54

1.0

1.1

0.97

2.02

u/ml

0.54

243

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

276

2284

1.21

2.53

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

269

1.64

2.51

1.7

1.6

9.62

9.03

ug/l

0.31

269

(3020356) Listeria sp identified in Specimen by Organism specific culture

108

2.04

2.51

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

296

2471

1.20

2.48

2.2

2.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.81

2.46

1.4

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.38

2.45

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

3.13

2.43

1.1

0.21

0.22

g/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

504

4405

1.15

2.43

1.5

1.6

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.90

2.41

3.0

6.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

5.00

2.40

1.0

1.2

—

(3017704) Immunofixation for Urine

336

1.55

2.39

1.4

1.6

—

(3020491) Glucose [Moles/volume] in Blood

717

1.37

2.38

1.8

1.9

5.74

6.15

mmol/l

0.73

552

(3006653) Thiamine [Moles/volume] in Blood

501

1.44

2.33

1.3

139.90

134.88

nmol/l

0.50

501

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

307

1.57

2.31

2.0

1.9

188.14

15183.44

u/ml

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

105

2.00

2.30

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

215

0.42

2.29

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

119

1.93

2.29

1.9

1.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.37

2.29

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

286

2402

1.20

2.28

2.3

5.89

6.18

umol/l

0.16

215

1768

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

4.62

2.27

1.0

—

(3012565) Volume of 24 hour Urine

433

0.55

2.26

2.5

2.1

2243.33

2002.94

0.46

402

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

120

1.92

2.24

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

209

1.68

2.22

1.5

1.6

0.28

0.41

ug/l

1.48

157

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.86

2.20

1.0

4.99

3.54

u/ml

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.68

2.20

3.0

3.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.68

2.20

46.4

7.2

110.18

103.22

g/l

1.08

(3021788) Differential panel - Synovial fluid

187

1514

1.24

2.17

1.6

—

1.00

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3996

38528

1.06

2.16

8.5

6.0

1.21

mmol/l

1.14

3816

35854

(3017446) Testosterone [Moles/volume] in Serum or Plasma

880

8018

1.11

2.16

2.3

11.94

12.32

nmol/l

0.67

808

7320

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

297

1.55

2.15

2.3

1.7

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.69

2.15

1.0

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

108

1.95

2.14

5.4

2.9

—

(4015189) Microbial culture of sputum

144

1.81

2.14

3.0

2.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

106

801

1.33

2.12

1.8

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

490

4322

1.14

2.11

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

220

1.64

2.11

1.3

1.6

0.26

nmol/l

0.02

158

(3009214) Lutropin [Units/volume] in Serum or Plasma

493

4353

1.14

2.09

1.4

11.31

9.41

u/l

1.93

395

3518

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

236

0.42

2.07

1.3

1.2

—

38.75

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.70

2.06

1.6

1.9

—

(3019225) pH of Specimen

707

7810

0.90

2.04

5.1

3.9

7.37

7.35

1.54

473

5656

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.32

2.04

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.18

2.04

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.98

1.94

2.2

3.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

546

1.38

1.94

1.9

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

649

1.34

1.93

1.6

1.8

1.85

2.44

u/ml

0.23

189

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

241

2030

1.19

1.92

1.1

0.19

0.52

u/ml

1.28

627

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

339

1.48

1.90

3.3

2.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

196

1.63

1.89

1.2

1.4

1.20

1.18

mmol/l

0.69

196

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.18

1.88

1.3

1.2

55.77

30.13

umol/24h

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

705

1.32

1.86

1.1

1403.56

1525.92

miu/ml

0.67

705

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

107

1.87

1.85

9.3

11.8

0.35

0.39

umol/l

0.21

(3014133) Dog dander IgE Ab [Units/volume] in Serum

281

2407

1.17

1.85

1.1

3.24

4.68

u/ml

1.08

162

1215

(3018291) Platelet Ab [Presence] in Serum

4.17

1.82

1.8

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

613

1.34

1.81

1.1

1.3

—

(3005033) Fetal Nuchal fold Thickness US

475

4230

1.13

1.81

1.4

1.5

1.29

1.26

1.03

372

3108

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

108

840

1.29

1.81

1.1

1.2

124.18

114.35

pmol/l

0.40

108

840

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

322

3702

0.87

1.80

1.5

57.50

60.09

ug/l

0.53

322

3702

(3044927) Protein electrophoresis panel - Urine

631

1.33

1.80

1.3

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

385

1.43

1.80

1.9

2.3

66.08

40.69

umol/l

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

687

1.31

1.74

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

102

793

1.29

1.73

1.5

1.2

—

(3032641) Amino acids panel - Urine

3.85

1.71

1.4

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

483

1.37

1.69

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

501

1.36

1.67

1.0

13.84

11.29

u/ml

0.40

337

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

119

1.77

1.65

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.80

1.65

1.1

1.0

1.71

3.44

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

102

801

1.28

1.62

1.5

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

120

1.75

1.61

1.2

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

793

1.28

1.61

1.5

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

114

909

1.26

1.60

1.3

1.2

56.90

61.49

u/l

0.32

104

798

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.60

1.0

1.1

—

(4133840) Spirometry

276

0.54

1.60

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.06

1.59

1.2

1.6

368.15

312.13

umol/24h

0.20

(40758292) HTLV I+II Ab panel - Serum

198

1.57

1.59

1.6

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

175

1.60

1.57

1.3

1.2

784.50

305.25

pmol/l

0.44

128

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

152

1.65

1.56

1.2

—

(3002256) Pathology report gross observation

1330

12525

1.07

1.55

1.3

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

122

986

1.24

1.53

1.3

1.2

7.00

47.86

u/ml

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

597

1.31

1.52

1.3

880.00

1037.74

titre

0.50

106

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

450

1.36

1.52

1.0

285.16

306.44

ng/l

0.31

332

(3017817) Protein [Mass] in Urine collected for unspecified duration

685

1.29

1.51

2.4

3.0

1286.32

1151.22

0.19

678

(3023323) Follitropin [Units/volume] in Serum or Plasma

759

8218

0.92

1.51

1.4

22.51

24.25

iu/l

0.83

606

7039

(3040893) Potassium [Moles/volume] in Capillary blood

2.86

1.50

3.5

1.6

4.98

4.50

mmol/l

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

123

1.71

1.50

1.1

1.2

1.57

1.68

mmol/l

0.19

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

452

1.35

1.48

1.0

784.19

763.09

ng/l

0.14

325

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.43

1.47

1.2

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

801

0.75

1.46

3.0

2.7

30.20

26.36

mg/l

0.40

566

(3024869) Neuronal Ab [Presence] in Serum

132

1.67

1.45

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

454

1.35

1.45

1.0

34.42

40.19

ng/l

0.67

328

(40768793) Breast Pathology biopsy report

278

2433

1.15

1.44

1.2

1.3

—

(40757373) Influenza virus identified in Isolate

140

1.64

1.44

2.5

1.3

—

(40763590) HLA-DQ beta [Type]

2.31

1.42

1.0

—

(40760410) HLA-B [Type] by High resolution

2.31

1.42

1.0

—

(40760409) HLA-A [Type] by High resolution

2.31

1.42

1.0

—

(46236302) HLA-C [Type] by High resolution typing

2.31

1.42

1.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

286

1.44

1.42

1.2

1.3

109.41

120.38

nmol/l

0.25

215

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

430

1.35

1.42

1.3

17.79

12.18

u/l

0.92

400

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

596

1.29

1.40

2.1

1.6

1721428.57

1580684.07

iu/ml

—

(3013862) HLA-DP [Type]

2.25

1.40

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

305

2696

1.13

1.38

1.3

3.25

3.59

ug/l

0.72

275

2473

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1690

16103

1.06

1.37

4.0

4.1

21.68

21.85

0.18

840

7069

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

610

5604

1.09

1.36

1.5

60.64

62.21

ug/l

0.35

520

4719

(3023430) Cat dander IgE Ab [Units/volume] in Serum

259

2267

1.15

1.36

1.1

5.61

5.38

u/ml

0.07

134

1044

(3010015) Selenium [Moles/volume] in Serum or Plasma

143

1.61

1.34

2.0

1.31

1.27

umol/l

0.23

103

(3001186) Copper [Moles/volume] in Serum or Plasma

307

1.40

1.33

1.2

1.3

16.84

16.70

umol/l

0.09

258

(3014891) Appearance of Pleural fluid

1.91

1.33

1.7

1.6

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.91

1.33

1.2

1.1

5.38

13.50

u/l

1.24

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.35

1.29

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

310

1.39

1.27

1.5

1.2

—

(3047181) Lactate [Moles/volume] in Blood

206

2368

0.87

1.25

5.2

5.4

1.31

1.27

mmol/l

0.15

193

2086

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

279

0.61

1.25

1.1

1.8

41.59

40.85

g/l

0.21

279

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

609

0.74

1.24

1.1

1.2

10.22

9.40

mm/h

0.18

609

(3020191) Ethanol [Moles/volume] in Serum or Plasma

912

0.79

1.23

1.9

1.5

1.39

1.29

promille

0.23

713

(3041806) Other cells [#/volume] in Blood by Manual count

779

1.23

1.22

1.5

1.4

0.52

0.51

e9/l

0.18

779

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.91

1.22

1.3

1.6

19.44

28.37

nmol/l

0.42

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.97

1.22

1.0

1.1

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.16

1.21

1.3

1.1

0.04

0.03

mg/l

—

(3034426) Prothrombin time (PT)

356

1.35

1.21

1.1

1.2

28.02

28.03

0.00

356

(40765089) Chromosome analysis panel - Blood by G-banded

559

0.73

1.20

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

164

1.53

1.19

1.1

0.79

0.73

umol/24h

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

140

1.57

1.19

1.7

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

272

1.40

1.19

1.1

33.60

34.10

iu/ml

0.02

272

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.11

1.18

1.5

5.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.50

1.15

4.2

6.8

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.50

1.15

2.0

2.2

28.58

27.82

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.81

1.14

1.0

1.1

25.93

24.60

u/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.85

1.13

1.5

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

376

0.69

1.09

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

882

1.20

1.09

1.3

1.4

1.37

1.48

nmol/l

0.56

100

793

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

1.64

1.09

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.82

1.08

1.6

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

538

4977

1.09

1.08

1.6

1.7

0.29

0.30

mg/l

0.11

235

2293

(3029612) Listeria sp Ab [Titer] in Serum

2.12

1.05

1.6

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

195

2217

0.88

1.05

4.4

3.3

55.71

57.60

1.29

195

2217

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

129

1.55

1.05

3.5

3.0

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.79

1.04

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

268

2402

1.12

1.04

1.1

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

2.27

1.03

1.2

1.4

133.88

135.34

nmol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.83

1.02

1.5

1.6

—

(4035726) Immunohistochemistry procedure

773

7268

1.07

1.02

1.4

—

(40768800) Prostate Pathology biopsy report

1172

0.83

1.02

1.2

—

(3022145) Colonoscopy Study observation

1134

10792

1.06

1.01

1.4

—

(3013290) Carbon dioxide [Partial pressure] in Blood

145

1676

0.86

1.00

5.8

3.8

4.99

5.02

kpa

0.15

145

1642

(3012501) Base excess in Blood by calculation

145

1675

0.86

1.00

5.8

3.8

2.42

mmol/l

0.00

1086

(3038026) Centromere Ab [Units/volume] in Serum

709

1.21

0.99

1.4

1.2

72.31

41.96

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

103

867

1.19

0.96

1.0

1.1

0.81

1.05

u/ml

0.21

220

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

1.85

0.96

2.3

1.7

62.00

56.16

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.2

—

31.66

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

279

2521

1.11

0.95

1.7

1.9

182.72

194.82

pmol/l

1.26

266

2405

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

325

2963

1.10

0.94

9.1

3.8

24.72

24.56

mmol/l

0.49

303

2766

(3033086) Enterovirus Ab [Titer] in Serum

2.22

0.93

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

101

1.58

0.93

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

601

0.78

0.93

8.8

7.1

24.06

76.42

ug/l

0.74

414

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

471

1.25

0.93

9.0

7.0

55.78

7182.64

u/ml

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.67

0.91

3.6

2.9

3.61

1.23

mg/l

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

407

0.74

0.91

3.2

2.6

1.03

1.17

ug/l

0.23

382

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

210

1.38

0.90

1.0

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

148

1688

0.88

5.5

3.8

8.66

8.84

kpa

0.66

148

1653

(1617658) Protocol used for examination of sentinel lymph nodes

672

0.80

0.87

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.72

0.86

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.82

0.85

1.4

2.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.82

0.85

1.4

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

489

4560

1.08

0.85

6.6

6.5

23.95

24.35

mmol/l

1.50

456

4353

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

299

1.31

0.85

3.1

2.8

27.36

28.18

umol/l

0.17

214

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

126

1093

1.15

0.85

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

204

1.37

0.84

1.5

1.3

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

251

0.68

0.84

1.5

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

251

0.68

0.84

1.5

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

251

0.68

0.84

1.5

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

251

0.68

0.84

1.5

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

104

1.54

0.84

1.0

1.2

3.93

1.95

mmol/l

0.23

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

177

1576

1.13

0.82

2.9

3.6

385.67

614.51

u/ml

0.37

161

1435

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.82

0.79

1.0

1.2

219.17

297.37

nmol/l

—

(3009883) Potato IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.12

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.79

0.0

1.0

—

0.11

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

149

0.60

0.78

1.4

1.3

5.66

5.68

mmol/l

—

149

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

162

1440

1.13

0.78

1.1

1.51

1.48

g/l

0.39

145

1328

(3035082) Kappa light chains [Mass/volume] in Urine

0.00

0.78

0.0

1.0

—

0.02

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.62

0.78

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.77

0.0

1.4

—

1.86

—

(40765096) Chromosome analysis panel by Banding

243

1.32

0.76

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1524

14725

1.04

0.76

1.8

1.47

1.40

2.90

1413

13187

(3007919) Fasciola sp Ab [Titer] in Serum

2.08

0.74

1.2

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.08

0.74

4.0

6.0

0.09

0.25

mmol/l

—

(3014271) Vancomycin [Susceptibility]

271

1.29

0.74

3.3

2.8

—

(3010937) Rubella virus Ab [Presence] in Serum

108

1.48

0.73

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.80

0.72

2.1

2.5

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1146

11023

1.04

0.71

1.6

3.40

3.46

mmol/l

0.95

759

7280

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.75

0.71

4.7

9.3

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.58

0.71

1.2

1.1

18.80

17.70

g/l

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.92

0.70

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

177

1.36

0.70

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

363

1.24

0.70

1.6

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

102

888

1.15

0.70

1.1

299.62

288.42

mg/l

0.77

823

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

454

1.21

0.69

2.1

2.2

8.97

9.28

mg/l

0.17

384

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.67

0.68

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

187

1.34

0.67

1.1

1.3

—

(3019174) dRVVT (LA screen)

102

1.47

0.67

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

498

4699

1.06

0.66

1.4

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

613

1.18

0.66

1.8

1.4

86.54

77.25

umol/l

1.05

613

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

330

1.24

0.66

3.7

4.1

—

(3048879) Bone marrow aspiration report

162

1.36

0.66

1.8

2.0

—

2.00

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

145

1.38

0.65

1.0

1.1

1.63

1.80

u/ml

0.03

101

(44806071) Cardiolipin IgM antibody measurement

171

1.35

0.65

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

791

8265

0.95

0.64

3.5

3.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

416

0.79

0.64

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

493

0.81

0.64

2.4

1.9

1.65

1.34

nmol/l

0.64

371

(3002331) Protein [Mass/volume] in Peritoneal fluid

163

1.35

0.64

1.4

1.3

310.81

24.47

g/l

0.49

118

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

146

1.37

0.63

1.5

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

2770

28265

0.97

0.61

4.1

3.7

0.00

estimate

3.91

1212

10228

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

721

1.15

0.61

1.2

1.07

1.05

ratio

0.39

599

(3002619) Bacteria identified in Specimen by Culture

253

1.27

0.60

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.44

0.58

2.1

2.8

13.05

9.58

—

(40768441) Liver Pathology biopsy report

705

1.15

0.58

1.6

1.5

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.58

0.0

1.3

—

19.99

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

123

1.38

0.57

1.1

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.45

0.56

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

195

0.72

0.56

38.1

6.6

5.92

5.99

kpa

0.13

180

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

560

1.16

0.55

2.2

1.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

148

0.68

0.55

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.58

0.54

1.2

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

796

1.13

0.53

12.7

13.3

0.59

0.60

mmol/l

0.14

735

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1485

14463

1.03

0.51

1.8

3.47

3.45

ratio

0.35

1098

10680

(3040151) Glucose [Moles/volume] in Capillary blood

102

912

1.12

0.51

3.5

12.1

7.39

7.08

mmol/l

0.32

754

(3029396) Erythrocyte agglutination [Presence] in Blood

554

0.85

0.51

3.3

3.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

207

2230

0.93

0.50

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

954

1.11

0.49

1.4

1.3

5.53

5.82

umol/l

0.29

854

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.48

2.7

2.5

0.73

0.60

ug/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

419

1.17

0.47

1.3

1.4

108.91

206.70

nmol/24h

0.66

419

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

741

0.88

0.47

1.3

169.06

181.65

pmol/l

0.31

741

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

549

0.86

0.47

1.2

3.80

10.82

u/ml

—

(3026726) Creatinine [Moles/volume] in Specimen

1.47

0.47

2.7

2.2

215.70

430.79

umol/l

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

772

0.88

0.46

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

165

0.73

0.46

2.7

2.6

1.20

1.19

mmol/l

0.21

155

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

353

0.82

0.45

5.8

6.4

9.86

8.54

0.58

353

(40761995) Spermatozoa Progressive [#/volume] in Semen

353

0.82

0.45

2.9

3.2

49.79

44.83

0.91

353

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

544

1.14

0.44

1.8

1.7

86.98

4.29

nmol/l

0.47

434

(3017315) Amylase [Enzymatic activity/volume] in Urine

502

0.86

0.44

1.1

1.2

203.78

300.06

u/l

0.89

461

(3052592) Norovirus Ag [Presence] in Stool

127

0.71

0.43

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

517

1.14

0.43

3.3

3.7

7.41

8.85

mg/l

1.25

409

(3013762) Body weight Measured

1.56

0.42

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.38

0.42

1.3

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.40

0.42

1.0

154.00

165.33

g/l

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

0.28

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.41

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

2378.19

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.38

—

(40758358) Immune stain study

1.47

0.40

1.0

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

204

0.78

0.39

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

178

1.24

0.38

2.4

1.6

—

(4281824) Cell count and differential, peritoneal fluid

996

0.91

0.36

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.36

0.36

1.2

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

179

0.78

0.35

38.0

6.8

6.36

5.42

kpa

0.83

179

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

236

1.19

0.34

1.5

1.8

5820.62

15247.70

e6/l

0.47

123

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

167

0.78

0.34

1.1

1.3

586.90

290.98

ug/l

—

(3003157) Bacteria [#/volume] in Mother's milk

1.30

0.33

7.8

7.4

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.67

0.32

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

267

2546

1.05

0.32

1.4

1.5

119.74

116.00

pmol/l

0.06

262

2482

(40768795) Lymph node Pathology biopsy report

874

0.91

0.32

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

144

1349

1.07

0.32

1.5

—

(3033099) Centromere Ab [Titer] in Serum

248

1.17

0.31

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

379

0.87

0.30

2.0

1.5

14.49

14.42

pmol/l

0.03

322

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

153

0.78

0.30

2.4

1.18

1.20

mmol/l

0.60

144

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

467

1.11

0.29

1.5

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.23

0.29

1.0

1.5

1016.67

565.63

nmol/l

—

(4212803) Bone marrow aspirate examination

1.23

0.29

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

345

1.13

0.28

2.0

61.08

180.89

ug/min

0.85

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

167

1.20

0.28

1.0

0.02

0.12

u/ml

1.04

100

(3036048) Francisella tularensis Ab [Titer] in Serum

233

1.16

0.27

1.2

1.1

—

178.46

—

(3022475) Manganese [Moles/volume] in Blood

1.23

0.27

1.3

0.14

0.17

umol/l

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.70

0.26

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.23

0.25

4.8

5.3

—

(3001556) Androgen free Index in Serum or Plasma

181

0.83

0.25

1.0

1.2

—

(3042631) Mycobacterium sp identified in Specimen

907

1.07

0.25

2.7

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

104

977

1.07

0.24

2.8

2.3

20.75

19.80

nmol/l

0.43

104

933

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

227

1.15

0.23

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.32

0.23

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

275

1.13

0.23

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

125

0.80

0.23

1.9

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

438

1.10

0.22

1.5

1.6

3.76

3.25

u/field

0.08

315

(4038314) Semen analysis, post vasectomy

0.77

0.22

1.0

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.75

0.22

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

157

0.83

0.22

1.0

1.2

54.62

63.15

ug/l

1.44

157

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.21

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1475.83

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

9.34

—

(3025577) Chromium [Mass/volume] in Blood

346

0.90

0.21

2.0

2.2

2.63

2.49

ug/l

0.10

293

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

262

0.88

0.21

3.0

2.7

46.29

97.91

ng/l

1.91

145

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

123

0.81

0.20

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

186

1791

1.04

0.19

1.0

1.1

4.04

3.13

eliau/ml

0.32

914

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.15

0.19

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

203

1.13

0.19

1.2

1.4

14.21

12.70

g/l

0.26

145

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

233

1.12

0.17

4.2

3.2

5.01

4.86

kpa

0.26

233

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.15

0.17

8.4

4.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

991

10049

0.98

0.17

1.5

1.6

1128.92

1000.57

mu/l

0.65

808

8611

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

527

0.93

0.17

1.5

1.8

189.57

193.25

u/l

0.17

522

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

234

1.11

0.16

4.2

3.2

10.24

10.66

kpa

0.47

234

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

120

1.17

0.16

1.0

1.1

2.07

0.19

u/ml

0.44

120

(3023487) Leukocytes [#/volume] in Peritoneal fluid

274

1.10

0.15

1.7

2.0

582.63

3662.09

e6/l

0.56

192

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

161

0.87

0.15

1.1

0.23

0.79

u/ml

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.11

0.15

1.9

2.1

0.89

0.72

u/field

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

538

1.06

0.14

1.9

1.6

5.84

6.66

u/l

0.17

439

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

450

4422

1.02

0.13

1.8

1.7

4.68

4.02

mg/l

0.52

341

3186

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

110

1059

1.04

0.13

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

159

0.88

0.13

2.5

1.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

513

1.05

0.11

1.0

1.1

11.39

10.43

u/ml

0.08

105

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

106

1026

1.03

0.10

4.8

4.9

168.68

71.23

u/ml

0.62

355

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

144

1.11

0.10

2.2

3.1

38.74

33.07

mg/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

241

1.08

0.10

2.2

2.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

339

1.06

0.10

1.6

1.7

53.20

181.72

au/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

207

0.92

0.09

1.0

4.93

7.12

u/ml

0.41

207

(3016330) Potassium [Moles/time] in 24 hour Urine

134

0.90

0.08

1.2

—

96.20

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

206

0.92

0.08

1.3

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.05

0.07

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.06

0.07

1.1

1.80

1.75

umol/24h

—

(40762365) Oxygen content in Arterial blood by calculation

111

0.90

0.06

1.7

2.7

15.42

14.68

ml/dl

—

103

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

497

0.97

0.06

1.0

96.11

93.23

0.29

401

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

969

0.98

0.05

2.0

27.26

23.45

mg/l

0.30

360

(3042517) Benzodiazepines panel - Urine

191

0.94

0.04

5.4

2.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

833

1.02

0.04

1.4

1.2

45.29

76.53

u/ml

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

269

2665

1.01

0.04

1.5

0.51

0.43

nmol/l

0.40

223

2109

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

191

1892

1.01

0.03

2.0

1.7

519.54

367.79

mu/l

1.28

156

1534

(43055514) Macroprolactin [Presence] in Serum or Plasma

430

1.02

0.02

1.1

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

129

1284

1.00

0.00

1.6

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

105

1.05

0.00

1.0

1.1

0.02

0.03

u/ml

1.35

105

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

106

1.04

0.00

1.0

0.41

0.22

u/ml

0.26

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

117

1.03

0.00

1.9

1.6

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

202

0.99

0.00

1.5

1.8

4.08

3.67

ug/l

0.06

116

(3044007) Cell count panel - Peritoneal fluid

240

1.00

0.00

1.6

1.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

100

1.00

0.00

1.1

112.00

88.32

titre

—

100

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.0

1.0

—

13.50

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

8.6

—

15.20

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

21.00

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3013931) Oligosaccharides [Presence] in Urine

0.00

0.0

1.2

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

1.7

—

12.33

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

47.33

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

22.63

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.96

-0.00

1.0

1.5

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.02

-0.00

3.2

3.4

—

0.00

estimate

—

Mortality – FinRegistry

↥

Association

Association between endpoint U22_COVID19_SUSPECTED and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have U22_COVID19_SUSPECTED.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: U22_COVID19_SUSPECTED – Covid-19 suspected case

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Covid-19 suspected case

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints